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IAbstract
Regular physical activity can lead to improvements in the immune system and so 
help to prevent many diseases such as cardiovascular disease (CVD), Type2 diabetes, 
and obesity.
The objectives of this study were to assess the antioxidant and trace element 
status in serum from adolescent, female gymnasts and pubertal controls of the same age, 
using ICP-MS, AAS to measure trace elements (selenium, copper, and zinc) and 
(magnesium), respectively. Enzymatic assay were also used to measure inflammation, 
auto-immunity and endothelial activation including (GPx, SOD, CRP, ICAM-1, HSP27 
antibodies and antigens IgG, and IgM). In addition, anthropometric, physical activity 
and dietary intake were estimated, as previously described (Nurmi-Lawton et al., 2004). 
Dual energy x-ray absorptiometry (DXA, Lunar DPX) was used to assess bone mineral 
content and density. The subjects of the current study, comprising 38 competitive 
gymnasts and 40 healthy, sedentary adolescent females, were part of a three-year long 
investigation into exercise and peak bone mass (PBM).
Most previous studies have not taken into account the possibility of confounding 
factors that include anthropometric differences and dietary intake, which are also likely 
to vary between active and less active subjects. In this present study, it was our 
objective to take these factors into account. Our findings show that young, female 
gymnasts have an altered antioxidant enzyme profile, serum inflammatory markers and 
endothelial activation, compared to their less physically active peers. The current study 
also found a significant, positive association between levels of serum Zn and indices of 
bone mass in the active group.
Further research should focus on examining the effect of vitamin D insufficiency 
on the above relationships and investigate further the interaction with and effect of 
hormonal changes and body weight.
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Introduction
21. Introduction
Dietary constituents including antioxidants, vitamins (vitamins A, C and E) and trace 
elements (selenium, copper and zinc) play an important role in the protection of cells 
against acute oxidant damage (Aydemir et al., 2000). They are therefore thought to be 
important in the prevention of chronic conditions, including cardiovascular disease and 
cancer, which are the major causes of death in Western societies (Visioli et a l , 2007).
An antioxidant may be defined as a substance that inhibits the effects of reactive oxygen 
species (ROS), or reactive nitrogen species (RNS), (Valko et al., 2006; Valko et al., 
2007). Mammals have developed several endogenous, antioxidant systems to modulate 
the effects of ROS and RNS, and these systems can be divided into enzymatic and non- 
enzymatic mechanisms. The major enzymatic antioxidants include superoxide 
dismutase (SOD), catalase and glutathione peroxidase (GPX); see Table 1.1. SOD can 
convert superoxide to hydrogen peroxide (H2O2) and water (1). GPx utilises reduced 
glutathione to eliminate H2O2 and lipid peroxides (2); several essential trace elements 
(e.g. copper, zinc and selenium) are important components of these enzymes, forming 
part of their catalytic sites (Aggett, 1985; Kuppusamy et al., 2005).
(1) O 2 + O 2 + 2H+ SOD  ^ H20 2 + 0 2
(2) 2GSH + H20 2 GPx  ^ GSSG + 2H20
(3) ROOH + 2GSH ___  ^ ROH + H20  + GSSG
The non-enzymatic antioxidants Table 1.1 include vitamins and non-vitamins, such as 
vitamin E, vitamin A, water-soluble and vitamin C. There are a number of other 
substances in blood which act as non-specific antioxidants. These include uric acid, 
bilirubin and albumin that are present in high concentrations in the plasma. Most of 
plasma protein is albumin, which serves as a carrier for hormones, (including thyroid 
hormones), and as a transporter of some fat-soluble, small amounts of ions (transferrin), 
which have bound to albumin. A low serum albumin may indicate malnutrition, 
although low levels are seen in protein-losing states, such as nephritic syndrome and 
protein-losing enteropathy.
Uric acid Table 1.1 is the final oxidation product of purine metabolism by xanthine 
oxidase (Becker, 1993), and may have a potential therapeutic role as an antioxidant 
(Glantzounis et al., 2005). One of the causes of uric acid reduction in the blood is a diet 
low in zinc, because zinc is linked to protein syntheses and hepatic amino acid degrading 
enzymes, which have an effect on metabolic reactions (Meiners et al., 1977; Alhaj et al., 
2007).
Bilirubin is a yellowish pigment excreted by the liver via the bile, which is produced by 
the reticular, endothelial system. It becomes elevated in plasma in obstructive liver 
disease and haemolytic disorders. Reduced serum bilirubin levels have been associated 
with increased risk of developing coronary heart disease (CHD), (Greabu et a l,  2001; 
Hunt et al., 2001). There are some factors which may interfere with the measurement of 
serum bilirubin, eg., haemolysis. Increased plasma bilirubin levels have been reported 
to develop during exercise (Banfi et al., 2007), whilst lipids have been shown to 
decrease the bilirubin level in animal models where a lipid free diet had been consumed,
plasma bilirubin had increased (Joshi et al., 1991). Bilirubin is derived from haem, 
which is present in haemoglobin, myoglobin or cytochromes, (Fevery, 2008). Biliverdin 
is oxidized to bilirubin, and is then transported to the liver bound to albumin, (Maghzal 
et al., 2009), after which it is excreted into the bile. Elevated levels are therefore found 
in patients with either increased haem turnover e.g. haemolytic disease (Valent and 
Lechner, 2008), patients with liver disease (Patel and Mutasim, 2002), or biliary disease 
(Lim et al., 1994).
Total Antioxidant Capacity (TAC) includes antioxidant vitamins, uric acid, bilirubin and 
albumin, and may be assessed by a simple colorimetric assay (Somogyi et al., 2007).
5Table 1.1 Classification o f  antioxidants, m odified from Fisher, 1988.
Antioxidant Role (Function) Remarks
En
zy
m
es
Superoxide Dismutase 
(SOD), Mitochondrial 
Cytoplasmic 
Extracellular
• Dismutase 02- to H20 2.
Contains Manganese 
(MnSOD)
Contains Copper & Zinc 
(CuZnSOD)
Contains Copper (CuSOD)
Catalase • Dismutase H20 2 to H20. Tetrameric hemoprotein nresent in oeroxisomes
Glutathione Peroxidase 
(GSH.Px) • Removes H20 2 and lipid peroxides.
Seleno-proteins (contains 
Se2+)
Primarily in the cytosol 
also mitochondria 
Uses GSH
N
on
-E
nz
ym
es
V
ita
m
in
s
Vitamin E 
(Tocopherols 
and tocotrienols
a, p, y, 5)
•  Breaks lipid peroxidation
• Lipid peroxide and 0 2- '  and - OH 
scavenger.
Fat soluble vitamin
The main function of alpha-tocopherols:
1) Antioxidant
2) Protects the fats (LDLs) from oxidation.
a - P carotene
• Scavenges - OH, 0 2-" and peroxy radicals 
that prevent oxidation of LDL and binds to 
transition metals.
Fat soluble vitamin
Ascorbic acid
• Directly scavenges 0 2-", -OH, and F120 2.
•  Neutralizes oxidation of LDL from 
stimulated neutrophils (Abdalla et al., 
1992).
• Contributes to regeneration of vitamin E.
Water soluble vitamin
N
on
-v
ita
m
in
s Albumin
• Transporter of thyroid hormones.
• Carriers of lipid soluble hormones, bile 
salts, unconjugated bilimbin, free fatty 
acids
• Calcium ions (Ca2+)
• Iron transport. Found in the blood
Uric Acid
Excessive amounts of uric acid can cause:
• Crystals to form in the joints
• Gout
Bilirubin •  Elevated in certain diseases.
The ions of some trace elements, such as copper and iron, are known under certain 
circumstances to be involved in the generation of free radicals that may subsequently be 
associated with DNA damage and tissue oxidation. These free radicals are also 
increasingly being implicated in the aetiology of chronic degenerative diseases 
(Halliwell, 1989). The trace elements which are thought to have a role in the defence 
against free radicals are copper, zinc and selenium. Zinc works to protect against the 
formation of ROS via the formation of Cu-Zn superoxide dismutase, which is present in 
the cytoplasm and mitochondrial membrane space of cells (Konig et al., 1999; Speich et 
al., 2001). Glutathione peroxidase, an enzyme which contains Se, can act to preserve 
the cell and its membrane and reduce inflammatory diseases (Margaritis et al., 1997; 
Shephard and Shek, 1998). Low levels of this antioxidant may cause oxidative stress 
and may therefore lead to cell injury (Barber and Harris, 1994). Free radicals and some 
other oxidants, such as hydrogen peroxide (H2O2) and hypochlorous acid (HOC1), can 
damage cells by starting chemical chain reactions such as lipid peroxidation, or by 
oxidizing DNA or proteins (Sies, 1997). Damage to DNA can cause mutations and 
thereby cancer, if not reversed by DNA repair mechanisms, while damage to proteins 
may cause enzyme inhibition, de-naturation and protein degradation (Stadtman, 1992; 
Valko et al., 2004).
There appears to be an association between the plasma concentrations of several trace 
elements (e.g., copper, zinc and selenium) and coronary risk, together with particular 
coronary risk factors. Selenium deficiency has been implicated in the aetiology of 
cardiovascular disease and other conditions, in which oxidative stress and inflammation 
are prominent features (Alissa et ah, 2006). Association between concentrations of trace
elements (zinc, iron, copper, magnesium, and selenium) in serum, is positively 
correlated with concentrations in heart tissue for selenium only (Oster et al., 1989). The 
turnover rate for selenium in tissue was similar to that in serum, but greater than that for 
erythrocyte selenium. Also, in heart tissue, serum ferritin correlated directly with the 
concentration of iron in tissues of the left ventricle, whereas other parameters such as Se, 
Cu, and Zn had not correlated (Oster et al., 1989). Overload of iron or iron stores are 
responsible for atherogenesis, by increasing free radical formation and oxidative stress; 
however, this is still controversial (Corti et al., 1997; Sempos et al., 2000; Zegrean, 
2009).
Copper is a transition metal that has been shown to promote the oxidation of low density 
lipoproteins (LDL) in vitro (Steinbrecher et al., 1984). Thus, putative atherogenic 
effects of copper may be mediated by increased oxidation of LDL. Catalytically active 
copper has been reported to be present in atherosclerotic lesions (Lamb et al., 1995) and 
caeruloplasmin, the copper-containing protein in plasma, can also catalyze LDL 
oxidation, as demonstrated by in vitro studies (Lamb and Leake, 1994). However, 
copper is also an essential micronutrient that affects several important biological 
processes, including the elimination of potentially toxic molecules, such as the 
superoxide radical (Ferns et al., 1997). Copper deficiency has been shown to be 
associated with hypertension, hypercholesterolemia, and diabetes mellitus in man 
(Klevay, 1980). Hence, it is possible that copper status influences cardiovascular risk by 
various mechanisms. However, it is unclear whether these epidemiological data reflect a
positive association between CHD and copper status pares, or whether raised serum 
copper levels are an indication of an underlying, inflammatory process.
It was hypothesised by Klevay (1993) that CHD is predominantly a disease of an 
imbalance between zinc and copper metabolism. He demonstrated that 
hypercholesterolemia in rats can be produced either by copper deprivation, or by 
increasing the dietary zinc to copper ratio (Klevay, 1993). The hypothesis is based on 
the axioms that; not all people share equally the risk of the disease; and that changes in 
serum cholesterol level, blood pressure, glucose tolerance and electrocardiographic 
abnormalities, are useful in coronary risk prediction. Furthermore, an inverse 
association between serum cholesterol and copper levels has been reported in humans, 
suggesting that copper depletion can result in an increased risk of cardiovascular disease 
(CVD), (Klevay et a l , 1984). Thus, there is uncertainty whether copper has pro- 
atherogenic or anti-atherogenic properties. It has been claimed that sub-optimal copper 
status, or marginal copper deficiency in Western populations is an important, but 
unnoticed, risk factor for atherosclerosis (Klevay et al., 1980). Perturbations in copper 
and zinc metabolism have been implicated in the aetiology of CVD, possibly through 
their effects on lipid metabolism (Kromhout et al., 1985). Several epidemiological 
studies support the possibility that increased serum copper concentrations and decreased, 
or normal, zinc concentrations may increase the risk of CVD (Niskanen and Wharton, 
1987; Kok et a l, 1988).
Caeruloplasmin, an acute phase protein, and the major carrier of copper in plasma, has 
been shown to predict coronary heart disease (CHD), (Reunanen et a l , 1992; Manttari et
a l,  1994). However, epidemiological evidence is difficult to interpret because 
measurements were made in patients with previous myocardial infarction (MI), which 
may have affected trace element levels. Changes in plasma copper and caeruloplasmin 
can be non-specific, secondary manifestations of inflammation accompanying 
atherosclerosis. A major difficulty in interpreting many of the studies relating to 
atherosclerosis, is the fact that plasma caeruloplasmin levels are often elevated in the 
presence of acute, or chronic, inflammatory disease (Singh et al., 1992). Moreover, 
copper may be related to CHD in other ways. LDL oxidation and free radical formation 
can be induced by excess copper (Lynch and Frei, 1993), whereas marginal copper 
levels inhibit SOD (Paynter, 1980).
Zinc has been implicated in the aetiology of cardiovascular disease through its effect on 
serum lipids (Klevay, 1975). With respect to changes in the level of serum zinc and 
copper in various conditions, zinc was found to decrease during the acute phase 
response, being associated with an increase of serum copper (Reunanen et ah, 1996). 
Experimental and clinical studies indicate that zinc deficiency may predispose to glucose 
intolerance, diabetes mellitus, insulin resistance, atherosclerosis and coronary artery 
disease (Kok et a l , 1988). It has been known for some time that in many inflammatory 
conditions, there is an increase in the concentrations of serum copper and 
caeruloplasmin, whilst there is a decrease in the concentrations of serum zinc; this being 
associated with increased hepatic storage and decreased levels of serum albumin, its 
major binding protein (Cousins and Swerdel, 1985). Experimental studies have shown 
that zinc protects against metabolic, physiological derangements of the vascular
endothelium and interferes with signalling pathways involved in apoptosis, whereas zinc 
deficiency causes an impairment of endothelial barrier function (Feliciano and Henning, 
1999). The results of epidemiological studies are inconsistent, although most of them 
found lower levels of serum zinc in patients with differing manifestations of CVD, than 
in apparently healthy controls (Oster et al., 1989). However, an intervention study 
conducted in men, did not support the hypothesis that zinc supplementation may provide 
antioxidant protection, by decreasing LDL-cholesterol oxidisability (Gatto and Samman, 
1995). Indeed, a high intake of zinc has been reported to lower HDL cholesterol (Black 
et al., 1988) and compromise antioxidant defences, through lowered SOD activity 
(Abdallah and Samman, 1993). These effects are probably the result of the well-known 
antagonistic effect of zinc on copper status.
Epidemiological studies on selenium and CHD have been inconclusive. Some reported 
increased myocardial infarction (MI) risk in subjects with very low serum selenium 
levels (Virtamo et al., 1985; Kok et al., 1988). As a result of geographic variability of 
selenium content in soil and food, a considerable variation in serum selenium levels 
exists. This relationship has not been confirmed by others (Miettinen et al., 1983; 
Ringstad et al., 1987). Hence there may be several explanations for the conflicting 
results of the reported epidemiological data. Low serum selenium may not be an 
independent CVD risk factor. The confounding affects of other dietary constituents in 
foods rich in selenium, or other lifestyle habits (e.g. alcohol consumption and smoking), 
cannot be excluded. Many of the negative studies were based on a relatively small 
number of patients and therefore had a restricted ability to detect any disease
associations with risk factors (Huttunen, 1997). Another possible explanation for the 
disparate results is a threshold in the effect of dietary selenium intake on risk. The 
results of the large, epidemiological studies are consistent with the existence of a 
threshold effect, as no association between coronary heart disease risk and serum 
selenium has been observed in populations with high serum selenium values (Salvini et 
al., 1995); the threshold value for serum selenium was approximately 45 pg/L (0.5 
pmol/L) in the Finnish population in whom the first studies were conducted (Salonen et 
al., 1982). Moreover, the antioxidant properties of selenium, as a part of GPx, may play 
an important protective role in the aetiology of CHD and is probably related to; 
decreased platelets aggregation, decreased production of thromboxane A2, and increased 
production of prostacyclin, all of which may potentially be linked to CVD with low 
plasma selenium levels (Salonen et al., 1988).
Hence, possible associations between trace element status and CVD may arise because 
of nutritional or metabolic imbalances, which have a direct effect on the cells of the 
vascular system, or which act via effects on lipid metabolism or lipoprotein oxidation. 
The latter process is mediated by an interaction between free radicals, released by 
activated leukocytes and other cells, as well as lipoproteins within the artery wall 
(Halliwell et al., 1996). Lipoprotein oxidation may be inhibited by antioxidants such as 
vitamin E (Jialal and Grundy, 1992), or by enzymatic antioxidants, such as glutathione 
peroxidase (GPx) and Cu/Zn-superoxide dismutase (SOD). The activities of these 
enzymes depend on a sufficient supply of selenium, copper and zinc respectively 
(Hussein et al., 1997). In the absence of sufficient antioxidant protection, lipoproteins
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become oxidized within the artery wall, leading to the release of lipid peroxides, and the 
formation of malondialdehyde (MDA)-modified lipoproteins (Haberland et al., 1988).
Heat shock proteins (HSP) are a class of functionally related proteins, whose expression 
is increased when cells are exposed to elevated temperatures or other stress (De Maio, 
1999). Heat shock proteins appear to serve a significant cardiovascular role. Hsp90, 
hsp84, hsp70, hsp27, hsp20, and alpha-B-crystallin have all been reported as having 
roles in the cardiovasculature (Benjamin and McMillan, 1998). Hsp27 is a molecular 
chaperone, whose expression is induced by a number of environmental stressors, 
including oxidative stress (Ferns et al., 2006). Its release may stimulate an auto­
immune response, and this study has previously reported that Hsp27 antibody titres are 
altered in patients with established CVD, or CVD risk factors (Ghayour-Mobarhan et al., 
2008).
Although diet may play an important role in the development of CVD, most of the 
published dietary studies have focused on the intake of macronutrients, rather than 
micronutrients. Table 1.2 shows the distribution of the three trace elements and vitamins 
in foodstuffs. Low copper intake rarely leads to copper deficiency due to its wide 
distribution among foodstuffs. Zinc is more generally available from animal sources 
than plant sources. Other dietary nutrients, such as protein and iron, might affect zinc 
bio-availability by reducing intestinal absorption of zinc. Consequently, selenium 
deficient soils can lead to a lack of element in the diet (Combs, 2001). Serum selenium 
levels have been widely used as an index of selenium status and in general, there is a
good association between serum selenium and the dietary intake levels (Levander, 
1982). The major sources of selenium in most diets are meats and cereal products.
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Table 1.2 Food sources of micronutrients, vitamins and trace elements
Antioxidant Food sources
Copper
Shellfish, crab meat, nuts, seeds, legumes, whole grains, 
liver and viscera, fruit, vegetables and chocolate
Zinc Oysters, meat, nuts, cereals, grains, and legumes
Selenium Sea food, vegetables, wheat, organ meat
Vitamin E
Vegetable oils (com, soybean, safflower), margarine, 
whole grain cereals, wheat germ, nuts, seeds and green 
vegetables
Vitamin A
Pro-vitamin A carotenoids: yellow and green vegetables 
Retinyl esters and carotenoids: Animal source (dairy 
products, fish, eggs, organ meat)
Vitamin C
Citrus fruit (strawberries, kiwi), papaya, green and red 
pepper, tomatoes, potatoes, spinach, peas and lettuce
p-carotene
Yellow-orange fruit (cantaloupe, grapefruit), carrots, 
tomatoes, apricot, sweet potatoes, yellow pumpkin, green 
leafy vegetables (spinach), broccoli
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1.1 Risk factors and predictive markers of cardiovascular disease
A risk factor is a term describing a characteristic of an individual, or a population, 
directly associated with the subsequent occurrence of a disease. For CVD, risk factors 
have been classified as either modifiable (lifestyle, biochemical and physiological 
characteristics) or un-modifiable (age, sex, and family history). A predictive marker 
may not necessarily have a direct, etiological effect on the disease, but may reflect 
disease burden. Conventional risk factors (Figure 1.1) are those risk factors that have 
been recognised for many decades, with substantial levels of supportive evidence, whilst 
several emerging risk factors have been identified, for which there is less evidence 
(Stanner, 2005). Dietary factors fall into the latter category. Dietary recommendations 
for CVD prevention have included a reduction in saturated fat intake in order to reduce 
serum cholesterol concentration. Weight control is best managed by reducing dietary 
energy density (Astrup et al., 2000), whilst physical inactivity has been found to be 
associated with high serum triglyceride and low serum HDL cholesterol concentrations 
(Koutsari et a l , 2001). High levels of plasma low density lipoprotein (LDL) cholesterol, 
and plasma triglycerides and low levels of high density lipoprotein (HDL), (Wood et al.,
1988) are now well established CVD risk factors, and this is supported by clinical 
intervention studies. Furthermore, cohort studies have also shown consistently, positive 
associations between markers of postprandial lipaemia and CVD risk (Tomg et al., 
2000; Burke et al., 2005).
Some recent reviews have discussed the comprehensive relations between lipoproteins, 
nutrition and heart disease, focusing on the novel lipid related risk factors (Palumbo et 
al., 2002; Schaefer, 2002). A summary of the relationships have been shown in Table
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Figure 1.1 Risk factors o f  cardiovascular disease.
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Table 1.3 Novel markers for the prediction of cardiovascular risk
Marker Example
Oxidative stress
TBARS
Conjugated dienes 
Ethane and pentane gases 
Isoprostanes
Lipid-related parameters
Lp(a)
PLA2
CETP
Apolipoprotein Al 
Apolipoprotein B
Serological markers*
Antigen
Antibodies
Micro-organism
Inflammatory markers
Acute-phase reactants 
Adhesion molecules 
Cytokines
Endothelial function Selectins
Adhesion molecules
Factors involved in clotting
Fibrinogen
PAI-I
t-PA
Factor VII 
Factor VIII 
vWF
Hyperuricemia 
Elevated homocysteine
Uric acid 
Folate
Vitamin B 12 metabolites
CETP: Cholesterol ester transfer protein, ICAM-I: Lp(a): Lipoprotein (a), MDA: 
Malondialdehyde, PAI-1: Plasminogen activator inhibitor type 1, PLA2: Phospholipase 
A2, TBARS: Thiobarbituric acid reactive substances, t-PA: Tissue plasminogen 
activator, vWF: Von Willebrand factor. * (Tavendale et al., 2002).
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1.2 Plasma lipoproteins
Plasma lipoproteins exist in four major classes: Chylomicrons, very low density 
lipoprotein (VLDL), low density lipoprotein (LDL), and high density lipoprotein (HDL). 
Three of the lipoproteins have been associated with risk of coronary artery disease 
(CAD): VLDL and LDL are positively associated with CHD, whilst HDL is negatively 
associated. Chylomicron particles contain apolipoprotein B-48 as the structural protein 
formed exclusively in the intestine and hence, may be a marker of postprandial lipaemia. 
VLDL particles are secreted by the liver, and are characterized by their apolipoprotein 
(apoB-100) content. In the plasma, lipoproteins contain different classes of apoproteins, 
for example, apoA, apoE and apoC, which have structural and functional properties. 
ApoC II, is an activator of lipoprotein lipase that stimulates the hydrolysis of 
triglycerides in chylomicrons, resulting in the formation of remnant particles of 
chylomicron. LDL is the major cholesterol containing lipoprotein, much of which is 
derived from the metabolism of VLDL. LDL contains apolipoprotein B-100, as its 
major protein constituent, and lesser amounts of lipoprotein E. HDL is mainly 
synthesised in the liver and intestine. Apolipoproteins A-I, A-II, and D constitute 
approximately 55% of the total protein content of HDL molecules. However, intestinal 
HDL does not contain apolipoprotein C and E, which are synthesised in the liver and 
added to intestinal HDL (Ginsberg et al., 1998).
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1.3 Endothelial dysfunction and atherosclerosis
The vascular endothelium usually provides anticoagulant, vasodilatory, and anti­
inflammatory functions to maintain vascular homeostasis. Endothelial dysfunction plays 
a key role in all stages of atherosclerosis and is characterized by deterioration of 
endothelial vasodilator function. Fatty streaks are the point of macrophage-derived 
foam cells, trapped beneath the endothelial cell lining of the artery. Continued 
recruitment of mononuclear cells and the attendant proliferation and migration of 
smooth muscle cells (SMC) result in fibrous plaques (Proudfoot et al., 1998). 
Atherosclerotic plaques may develop a necrotic lipid core, with increased numbers of 
macrophages and fewer SMC that predispose to plaque rupture (Libby et al., 1995). 
This leads to platelet activation, thrombosis, and embolism and results in Acute 
Coronary Syndrome (ACS) (Davies and Arsiwala, 1996). It is therefore thrombosis, 
superimposed on mature atherosclerotic plaques, which may be responsible for unstable 
angina, acute myocardial infarction (AMI), and sudden cardiac death (SCD). 
Accordingly, plaque composition and thrombogenicity have emerged as being much 
more important than plaque size and stenosis severity (Libby, 2001). Substantial 
evidence in basic and experimental science has illuminated the role of inflammation and 
the underlying cellular and molecular mechanisms that contribute to atherogenesis. 
Atherosclerosis is now believed to be an inflammatory process, driven by inflammatory 
cells, in particular macrophages, in association with sub-endothelial deposition of lipids 
in the artery wall (Ross, 1999). Macrophage recruitment and activation occurs in 
response to chemotactic and pro-inflammatory molecules, that help define and localise
the inflammatory response at lesion sites. Continuing entry, survival, and replication of 
monocytes depend on the local production of cytokines, which are up-regulated by 
modified lipids (Rajavashisth et al., 1990). Cytokines and growth factors, secreted by 
the activated inflammatory cells, attract SMC into the intima. The migration and 
proliferation of SMC are facilitated by loss of contractile proteins and expression of 
matrix metalloproteinase (MMP), growth factors and matrix proteins, which also 
facilitate synthesis of the matrix component of the fibrous cap (Shanahan and 
Weissberg, 1998), Figures 1.2,1.3.
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Figure 1.2 Foam cells formation. LDL oxidation, then proliferation and m igration o f 
smooth muscles cells into intima. The following review focusses on atherosclerosis, 
m odified from Lusis, (2000).
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NOMANCLATURE AND SEQUENCES IN PROGRESSION e a r l i e s t  m a in  g r o w t h  c l i n i c a l
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Figure 1.3 Stages o f endothelial dysfunction in atherosclerosis; (from; en.wikipedia 
2007-03-03 (la st version ), by Jrockley).
1.4 Oxidized-LDL
The oxidative modification of LDL appears to be an important process, linking 
hyperlipidemia and the development of atherosclerosis. Various initiators of lipid 
peroxidation, such as metal ions and nitric oxide, can oxidize LDL (Berliner and 
Heinecke, 1996). Substantial evidence indicates that ox-LDL plays a major role in the 
pathogenesis of atherosclerosis (Steinberg et al., 1989). Ox-LDL exhibits many 
atherogenic activities, including chemotaxis for T lymphocytes and macrophages, 
cytotoxicity towards endothelial cells, and induction of pro-inflammatory genes (Reaven 
and Witztum, 1996). Oxidised lipoprotein particles and lipid peroxidation products have 
been detected in atherosclerotic lesions. As mentioned earlier, the appearance of lipid 
laden foam cells is a characteristic event in the early stages of the development of 
atherosclerosis. Hypercholesterolemia is usually associated with an elevation of LDL, 
which is the ultimate source of cholesterol that accumulates in developing foam cells. 
An increment of LDL levels in lumen and/or sheer stress lead to an increase in the 
adhesion of circulating monocytes and T cells to arterial endothelial cells and also to an 
entry of LDL and/or ox-LDL into the intima. Ox-LDL is also avidly taken up by 
macrophages via several types of receptors, greatly enhancing intracellular cholesterol 
accumulation and foam cell formation. LDL oxidation also affects gene regulation of 
vascular cells and promotes expression of a number of cell adhesion molecules (CAM-1) 
and chemotactic proteins (MCP-1) by endothelial cells that may, in turn, contribute to 
lesion formation (Steinberg et al., 1989).
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1.5 Inflammatory markers
Inflammation is an essential element of atherogenesis throughout all stages, from the 
first step, through progression, until thrombotic complication (Ross, 1999). 
Accordingly, sensitive assays have been developed to detect low-grade inflammation 
that may be used as a marker of vascular risk. These include high sensitivity C -reactive 
protein (hsCRP) and intercellular adhesion molecule-1 (ICAM-1), which have been used 
in cohort studies for evaluating their importance in cardiovascular outcomes (Stenvinkel 
et a l , 2000). Since atherosclerosis has been recognised as an inflammatory disease, 
attention has focussed on the potential role of plasma markers of inflammation, as risk 
predictors of cardiovascular events (Blake and Ridker, 2001). Contributing to the 
progression of atherosclerosis, inflammatory responses may either be local - manifested 
as the activation of cells within the plaque microenvironment itself - or systemic, 
evidenced by acute phase protein production and circulating, pro-inflammatory 
mediators (Risio and Rossini, 1993). Locally produced inflammatory mediators include 
products of activated macrophages, such as Tumour Necrosis Factors Alpha (TNF-a) 
and Interleukin-1 and 6 (IL-1 and IL-6), that are produced in response to oxidation of 
low density lipoprotein (ox-LDL). Systemic mediators include C-reactive Protein (CRP) 
and Serum Amyloid A protein (SAA). Inflammatory mediators that influence the 
development of atherosclerotic lesions in animal models can either have pro- 
atherogenic, or anti-atherogenic, characteristics. Inflammation begins with primary, pro- 
inflammatory cytokine stimulation of the secretion of chemoattractants, such as 
monocyte chemoattractant protein-1 (MCP-1), chemokines such as interleukins, growth
factors, and cell surface adhesion molecules that bind monocytes; see Table 1.4. All of 
these may play a major role in atherogenesis and can be used as markers of 
inflammation (Liao, 1998). In the intimal space, monocytes and T-lymphocytes 
modulate inflammatory response and form foam cells with intimal thickening, plaque 
formation and vessel narrowing (Alexander and Damoulis, 1994). This also includes the 
secretion of matrix metalloproteinase (MMPs), disruption of type I collagen and plaque 
disruption. Moreover, primary pro-inflammatory cytokines stimulate the production of 
secondary, pro-inflammatory cytokines such as IL-6 which, in turn, stimulate the 
production of acute phase proteins, CRP, by the liver (Castell et al., 1989). Many 
inflammatory markers have been proposed to be of both indicative and prognostic values 
at different stages of atherosclerosis, among other novel markers.
CRP circulates and binds to damaged membranes and proteins; fixes complement and 
optimises the removal of the target by the endothelium. The sequence of events 
involved in the inflammatory cascade is illustrated in Figure 1.4. The participation of 
oxidative stress and immune responses in the pathogenesis of atherosclerosis is well 
established (Berliner et al., 1995). Therefore, if  atherosclerosis is viewed as an 
inflammatory condition, it is conceivable that acute-phase reactants will be elevated to 
an extent that is proportional to the magnitude of the lesion size.
During inflammation, serum concentrations of the most sensitive acute-phase-proteins, 
CRP and SAA, can rise up to 10,000 fold (Pepys and Baltz, 1983). In recent years, these 
"acute-phase reactants" have been studied as potential markers of more subtle and
persistent systemic alterations, that may be called "low-grade inflammation" (Danesh et 
al., 2000). Low-grade inflammation is thereby manifested in patients with increased 
plasma levels of cell adhesion molecules, interleukins, oxidative stress, activation and 
translocation of Nuclear Factor Kappa B (NF-KB), together with increased plasma 
levels of CRP.
28
Table 1.4 Serum inflammatory markers*.
IL-I
TN F-a
Pro-inflam matory IL-6
TT O
cytokines IL-8
M CP-I
IFNy
P-selectin
E-selectin
Adhesion m olecules S-selectin
ICAM -I
VCAM -I
CRP
Acute phase reactants Fibrinogen
SAA
CRP: C-Reactive Protein, IFNy: Interferon-y, IL-1: Interlukin-1, IL-6: Interlukin-6, IL-8: 
Interlukin-8, MCP-1: M onocyte Chem otactic Protein-I, SAA: Serum Amyloid A Protein, 
TNF-a: Tum or Necrosis Factor-a. *(Biasucci, 2004).
Oxidized
LDL
Endothelium and 
cells (mac.)Adipose Tissue
ICAM-1,
selectins
IL-6,
TNF-a IL-1, TNF-a
Heart
CRP, SAA Liver
Figure 1.4 Sequence o f inflammatory cascade. Pro-inflam matory risk factors, such as 
ox-LDL, cause local or systemic inflammation, which triggers the production o f  prim ary 
pro-inflam m atory cytokines, such as interleukin-1 and tum or necrosis factor-a. Prim ary 
pro-inflam m atory cytokines and ox-LDL activate the endothelium and the expression o f 
adhesion molecules that are crucial to the recruitment o f inflammatory cells from the 
blood stream into the vessel wall, briefed from (Castell e t  a l., 1989; Alexander and 
Damoulis, 1994).
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1.6 Elements of the inflammatory response
The immune system consists of lymphoid organs, circulating immune cells 
(lymphocytes, NK cells and monocytes), humeral factors and cytokines, which work 
together as a host defence system. The immune system has two distinct roles 
(natural/adaptive). Innate or natural immunity is conferred by granulocytes, monocytes, 
macrophages and natural killer (NK) cells, whereas lymphocytes are a part of the 
adaptive immune system. Usually, the natural and adaptive immune systems 
communicate with each other by direct cell-to-cell contact, involving adhesion 
molecules and chemical messengers. Cytokines are used as the key messengers. In 
addition to tumour necrosis factor alpha (TNF-a), interleukin-1 (IL-1) and interleukin-6 
(IL-6), are produced by monocytes and macrophages. Several cytokines increase the 
expression of adhesion molecules (ICAM-1) by endothelial cells in the arterial wall. 
The liver responds to the action of the cytokines by increasing the synthesis of acute 
phase proteins such as C-reactive protein (CRP).
1.7 Response to injury theory
The presence of macrophages and activated lymphocytes in the atherosclerotic plaque 
has raised the concept of atherosclerosis as an inflammatory disorder (Ross, 1993). 
According to the "response to injury" hypothesis of atherosclerosis, endothelial 
dysfunction is the first step in atherosclerosis, as illustrated in Figure 1.5 (Ross, 1999). 
A number of factors may contribute to endothelial dysfunction, such as hypertension,
diabetes mellitus; free radicals caused by smoking, and increased LDL levels. 
Endothelial dysfunction results in increased adhesiveness of the endothelium to 
leukocytes and platelets and increased permeability. The injury also induces the 
endothelium to have pro-coagulant instead of anti-coagulant properties and to form 
growth factors. The ongoing inflammatory response stimulates proliferation of SMC, 
which become intermixed in the area of inflammation, to form an intermediate lesion. 
This response is mediated by monocyte derived macrophages and leads to the release of 
hydrolytic enzymes, cytokines, chemokines and growth factors, that lead to focal 
necrosis and plaque rupture. The cycle of accumulation and formation of fibrous tissue 
leads to fibrous cap. At some point, when the artery can no longer dilate, the lesion may 
intrude into the lumen and alter blood flow, leading to clinical signs and symptoms of 
ischemia.
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Injury caused by oxidized LDL, tobacco, 
visceral obesity, diabetes, inactivity
Figure 1.5: Response to injury hypothesis o f atherosclerosis. (1) Chronic endothelial 
injury. (2) Endothelial dysfunction. (3) Smooth muscle cells em igration from m edia to 
intima. M acrophage, activation. (4) M acrophages and smooth m uscle cells engulf lipid. 
(5) Smooth muscle proliferation, collagen and other extracellular m atrix deposition, 
extracellular lipid. Each o f the stages o f  lesion form ation is potentially reversible. 
M odified from; (Ross, 1993).
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1.8 Pathogenesis of athrosclerosis
Several theories have been proposed concerning the aetiology pathogenesis of 
atherosclerosis. Ross and Glomset (1976) initially proposed that vascular, smooth 
muscle cells (SMC) migrate from the tunica media of the arterial wall to the intima, and 
were considered as the origin of so-called foam cells in the early stages of 
atherosclerotic changes (Ross and Glomset, 1976). However, this has been called into 
question since the discovery of the LDL pathway by Goldstein and Brown (1977), which 
also drew attention to the role of modified LDL and macrophages in the initial stage of 
the process of atherogenesis (Goldstein and Brown 1979). Steinberg and his colleagues 
(1989) have based their findings on the modification of oxidative LDL (Steinberg et a l,
1989). They hypothesised that various modifications of LDL increase its atherogenicity. 
Since then, oxidatively modified LDL has received increasing attention in the field of 
atherosclerosis research. Afterwards, many researchers who worked on the problems of 
the relation between plasma lipid peroxides and atherosclerotic diseases, have found that 
the lipid peroxide content of the blood was higher in patients with atherosclerotic 
diseases and suggested that lipoperoxides in the circulation were the cause of 
atherosclerosis (Kovacs et al., 1997).
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1.9 Antioxidants and their importance for cardiovascular health
Some antioxidants appear to inhibit the formation of atherosclerosis in animal models 
(rabbits), in which high cholesterol diets have been used (Ozer et al., 1998). However, 
whilst some early research suggested that antioxidant supplements could prevent CVD 
(Yuen et al., 2005), this has not been a consistent finding in clinical intervention studies 
(Stocker, 1999). Indeed, some studies indicate that antioxidant supplements, which 
contain antioxidants at higher levels than in food sources, may have harmful effects; for 
example, vitamin E might displace other fat-soluble antioxidants, resulting in an increase 
in oxidative damage (Lock and Loblaw, 2005). Several previous studies of vitamin E 
suggest that people who take more than 400 international units of vitamin E per day, are 
at greater risk of death when there are no other differences in causes of mortality (Millen 
et al., 2004; Lock and Loblaw, 2005). These findings are the reason why the American 
Heart Association (AHA) does not recommend routine use of antioxidant supplements to 
prevent or treat cardiovascular disease. Instead, the AHA supports a diet high in food 
sources of antioxidants and other heart-protecting nutrients, (such as fruit, vegetables, 
whole grains, and nuts), to reduce the risk of cardiovascular disease (Kris-Etherton et al., 
2004).
Antioxidants, when present in sufficient concentrations, can scavenge free radicals and 
prevent their reaction with other molecules, such as fatty acids, thereby preventing auto- 
oxidation and subsequent development of fat rancidity (Aruoma et al., 1991). Two 
potentially important antioxidants are vitamin E (tocopherols and tocotrienols) and
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vitamin C (ascorbic acid), as they can reduce LDL modification by the processing of 
removing superoxide (O2 ’)> and converting it into hydrogen peroxide (H2O2) and 
oxygen, as shown in the following equation; actually, antioxidants work by neutralising 
free radicals, by accepting or donating an electron, to eliminate the impaired conditions.
02* + 02* + 2HH— > H2O2 + O2
Hydrogen peroxide (H2O2) is poorly reactive compared to other ROS, but uncontrolled 
production of ROS could cause oxidative damage to various biological macromolecules, 
such as nucleic acids (Deoxyribonucleic acid DNA, Ribonucleic acid RNA), lipids, 
proteins and carbohydrates (Hemnani and Parihar, 1998; Blokhina et al., 2003). It also 
becomes more toxic to cells in the presence of free transition metal ions, such as Fe2+ or 
Cu2+ due to the formation of hydroxyl radicals. There are several ways by which
hydroxyl radicals can be formed; the most important of these is called Fenton's reaction, 
in which hydrogen peroxide and an iron catalyst work to destroy organic compounds 
such as trichloroethylene (TCE) and tetrachloroethylene (PCE) as shown here:
Fe2+ + H2Oz____ ► Fe3+ + O H + O H
Fe3+ + H20 2 -------► Fe2+ + OOH" + H+
Reactive oxygen species (ROS) are small molecules, which are highly reactive, due to 
alterations in the valence shell electrons; their capacity to cause damage is varied but
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mostly, they are highly toxic to the cells and can be involved in chronic degenerative 
diseases. ROSs, such as superoxide anion, hydrogen peroxide, singlet oxygen, and 
hydroxyl radicals, are involved in subsequent killing of bacterium and other substances 
(oxidative stress). Potentially, the most important effect of some antioxidants is their 
ability to inhibit the oxidation of low density lipoproteins (LDL), thereby reducing the 
formation of lipid laden foam cells and preventing the development of coronary heart 
disease (CHD), where oxidative modification of LDL is considered to play a significant 
role in atherogenesis in humans (Steinberg and Witztum, 2002).
1.10 Glutathione Peroxidase
In 1957, Mills discovered glutathione peroxidase (Mills, 1957). Glutathione peroxidase 
is an antioxidant enzyme that works to prevent lipid peroxidation of the cell membrane: 
It reduces lipid hydroperoxides to their alcohols and reduces free hydrogen peroxide to 
water, by donating electrons, where they can act as radical scavengers.
2GSH + H20 2 —► GSSG + 2H20  
GSSG + NADPH + H* —> 2GSH + NADP+
Glutathione peroxidase (GPx) has four selenocysteine amino acids, that are also present 
in several other enzymes, such as thioredoxin reductase, glycine reductase and some 
hydrogenases, which are involved in chemical reactions in many of the body’s different 
organs, such as the brain, heart, liver, kidneys and small intestine. In animal
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experiments, deficiency of selenium may be associated with reduced enzyme activity 
(Elsayed et al., 1983; Chandra and Chandra, 1986; Venardos et al., 2004).
Glutathione status in cells can be used as an indicator of the redox status of the cell 
(Schafer and Buettner, 2001). Decreased glutathione (GSH) levels and increased 
oxidized glutathione (GSSG) levels, in cases of oxidation stress, were widely believed to 
be a major cause of degenerative disease, where it has been observed that despite the 
reduced level of lipid peroxidation products, antioxidants can improve the immune 
system (Meydani et al., 1998; Jones et al., 2002).
Oxidative stress occurs when pro-oxidants, potentially harmful compounds that damage 
tissue and cells, exceed the levels that can be neutralised by antioxidants. Superoxide 
radicals are converted to hydrogen peroxide by Zn/Cu superoxide dismutase (SOD) 
(Gerli et al., 1990). Figure 1.6 shows enzyme systems, including glutathione peroxidase 
(GPx) and catalase (CAT), independently convert hydrogen peroxide to water (Gerli et 
al., 1990). Oxygen is converted to superoxide anion, singlet O2, and hydroxyl radicals, 
from peri hydroxyl radicals, by nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase, and is further converted to hydrogen peroxide by superoxide dismutase 
(Venarucci et al., 1999).
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A) B)
GSH + NADPG-S-S-G
NADP + H
GS-SGGSH
Figure 1.6 Glutathione peroxidase catalyzes: A) The full cycle o f glutathione. B) 
Glutathione structure. GSH, Glutathione. GSSG, Glutathione oxidase. H, Hydrogen. 
H 2 O 2 , NADPH, Nicotinam ide adenine dinucleotide phosphate.
1.11 Antioxidants and physical activity
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The capacity of both antioxidants and dietary antioxidants are effected by regular 
exercise (Watson et al., 2005). In addition, other researchers have found that serum GPx 
activity was significantly higher throughout exercise (Kanaley and Ji, 1991; Kostka et 
al., 2000; Selamoglu et al., 2000; Rush and Sandiford, 2003; Knez et al., 2007). The 
effects of the type of the physical activity, either acute or chronic, on vascular function 
have also been reported. Wang and his colleagues have studied the effects of chronic 
exercise on platelets function in women for 5 days and 30 min/d. During this period, 
they found that heart rate and blood pressure were reduced and exercise performance 
was improved; platelet function (guanosine 38,58-cyclic monophosphate (cGMP) 
content, and plasma nitric oxide metabolite levels) was measured, whereas plasma 
nitrite, nitrate levels and platelet cGMP contents were increased; however, acute 
exercise decreased the potentiation of platelet function (Wang et al., 1997). In an animal 
study, Chen and Liao have shown a relationship between chronic exercise and 
endothelial muscarinic M receptor, for acetyl choline (Ach) induced vasorelaxation in 
the thoracic aorta of male rats. The sub-class of M receptor in endothelium was 
identified on the basis of the affinity of selective antagonists i.e., pirenzepine M l, 
gallamine M2, and 4diphenylacetoxy-N-methypiperidine methiodide M3. They found 
ACh-induced vasorelaxation was mediated by M3 receptor; chronic exercise enhanced 
ACh-evoked vasodilating responses. However, this modification was not caused by 
receptor up-regulation, as maximal binding sites and affinity of M3 receptor were not 
changed by chronic exercise (Chen and Liao, 1998). Much research on acute physical
activity has also been reported; for example, acute exercise such as bicycle riding can 
increase pulmonary activity with NO excretion that can be linked to cardiovascular 
responses (Bauer et a l, 1994). This study also highlighted the relationship between long 
distance running and lipid oxidation, where no change was reported in LDL diene 
conjugation (LDL-DC or LDL) antioxidant potential (LDL-TRAP) concentrations 
during acute exercise (Vasankari et al., 1997). In an animal model study, acute 
swimming exercise was associated with changed plasma trace elements such as Cu, Fe, 
P, Se, and Zn levels, according to different periods of exercise, e.g. immediately after 
30min. of exercise Se and Zn had decreased but P had increased; after 24h of exercise, 
all parameters had increased except Mg; and after 48h, all of them were restored to 
control (Baltaci et a l, 2009).
Nemet and his colleagues have demonstrated short and long-term beneficial effects of 
combined, dietary-behavioural-physical activity intervention for the treatment of 
childhood obesity, and the importance on health (Nemet et a l, 2005). Table 1.5 shows 
that physical activities also have different effects on CVD, either by reducing, 
improving, or increasing these factors.
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Table 1.5 Impact of physical activity on factors affecting cardiovascular risk (Ren, 2004; 
Krentz, 2006).
Physical activity cause
Adiposity
Insulin resistance
Reduces
Hypertension
Inflammation
Lipid profile (HDL)
Endothelial function
Improves
Coagulation related factors
Adipose derived factors
Increases Oxidative stress
No affect Homocysteine
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1.12 Free radicals and health
For 60 years, biochemists and biologists have believed that free radicals play a role in 
life processes (Davies and Pryor, 2005), and the first organic free radicals were found in 
1900. Gomberg first described the existence of the triphenylmethyl radical (PhsC*) as 
an “organic free radical” (Gomberg, 1900). Since then, other free radicals have been 
identified (Aruoma et al., 1991). Free radicals are highly reactive chemical species, 
containing one or more unpaired electrons in their outer shell. They can donate, or 
accept, an electron from another molecule, or may combine with non-radical species.
ROS have been associated with several degenerative diseases, including osteoporosis 
(Sheweita and Khoshhal, 2007), CVD (Kumar et al., 1991) and many other diseases, 
such as diabetes (Witz 1991), and cataracts (Opara, 1998). Studies have demonstrated 
that ROS can oxidise low-density lipoproteins, which are implicated in the development 
of CVD (Shivalkar et al., 1993). Free radicals may derive from activated granulocytes, 
such as neutrophil, eosinophil, and basophil, and are potentially very cytotoxic. For 
example, superoxide radicals, derived from leukocytes, may cause extensive synovial 
joint injury (Salin and McCord, 1975). In animal experiments that have been 
ovariectomised, there appears to be a correlation between free radicals and bone loss, 
where the levels of lipid peroxidation and H2O2 increased, and enzymatic antioxidants 
such as SOD, GPx, and glutathione S-transferase (GST) decreased when compared to 
controlled rats (Muthusami et al., 2005). Furthermore, there was a strong correlation 
between the production of H2O2 and lipid peroxidation (LPO) in the femur bone of rats
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(Muthusami et a l , 2005). Ovarian hormones are important in the maintenance of bone 
tissue, so any deficiency in these hormones may increase the risk factors for 
osteoporosis (Riggs et a l , 2002).
Free radicals are not always harmful or dangerous; they are also useful chemicals for 
many important functions of the immune system and other cellular activities. For 
example, they are used by macrophages against foreign bodies, such as micro-organisms 
and abnormal cells (al-Tuwaijri and Mustafa, 1992).
1.13 Trace elements
Trace elements are nutrients that are needed in very small quantities (generally < 
lOOpg/day). Several of these trace elements play a role in catalysis, as components of 
enzymes in body tissues are essential for optimal human growth, health, and 
development. In general, trace elements exist in two forms; 1) as charged ions, or 2) 
bound to proteins e.g., metalloenzymes, where, according to the different chemical 
properties of each element, they provide a critical function in cells. The dietary 
reference intakes (DRIs) have established nine essential trace elements: Chromium, 
copper, iodine, iron, manganese, molybdenum, selenium, zinc, and fluoride. Some trace 
elements are involved in the defence of antioxidants and these include: Selenium (Se), 
copper (Cu) and zinc (Zn) (Mahan, 2004).
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Both selenium and copper are essential for antioxidant compounds to prevent 
accumulation of toxic peroxides. Copper is also involved in the biosynthesis of 
collagen, which forms the extracellular matrix (Ferns et al., 1997). Trace elements, such 
as copper and zinc, are normally found in biological fluids (e.g. blood), in 
caeruloplasmin, or with low, molecular weight portions, such as metallothionein state 
(Ngu and Stillman, 2006). The enzyme caeruloplasmin, synthesised in the liver, 
contains 8 atoms of copper and is a copper transport protein. Zinc is an important 
element for human metabolism, being a component of more than 300 enzymes, 
including alcohol dehydrogenase and alkaline phosphatase. In addition, zinc is found in 
the body in small amounts of trace minerals and is second in concentration to iron.
1.14 Bone health
A balanced diet is essential for the normal development and maintenance of the skeleton 
and for the prevention of osteoporosis. Such a diet can prevent bone disease through 
adequate intakes of calcium and other nutrients during development. Osteoporosis is a 
disease characterised by low bone mass and gradual loss of bone tissue, with an increase 
in bone weakness and susceptibility to fracture (Dempster, 2000), see Figure 1.7.
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Figure 1.7 Difference between (a) normal and (b) abnormal bone tissue (Dempster, 
2000).
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1.14.1 Structure of bone
Bone consists of a protein matrix encased in crystalline minerals, where minerals are 
involved in providing bone strength. Bone has several different functions, including 
support, protection, movement, storage, and blood cell formation, in addition to giving 
shape and form to our bodies. The organic parts of the matrix make bone flexible; 
calcium salts deposited in the matrix make bone hard. Usually, bones change in shape 
throughout a lifetime by the process of remodelling and with the effects of parathyroid 
hormones (PTH) and mechanical stress (Marieb; and Hoehn, 2007).
1.14.2 Composition of bone
Bone consists of an organic matrix or osteoid, primarily comprising collagen fibres, in 
which salts of calcium and phosphate are deposited in combination with hydroxyl ions, 
in crystals of hydroxyapatite. The tensile strength of collagen and the hardness of 
hydroxyapatite combine to give bone its great strength. Other components of the bone 
matrix include osteocalcin and osteopontin, together with several other matrix proteins 
(Boskey and Posner, 1984).
1.14.3 Types of bone
There are five types of human bone; long, short, flat, irregular and sesamoid. The 
skeleton is made up of about 80 percent compact (cortical) bone tissue. The long bones
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are primarily cortical bone. The remaining 20 percent of the skeleton is trabecular 
(cancellous) bone tissue, which exists in the ends of the long bones, the iliac crest of the 
pelvis, the wrists, scapulas, vertebrae, and the regions of bones that line the marrow.
Trabecular tissue is less dense than cortical bone tissue, and spongy bone. Trabecular 
tissue adds support to the cortical bone tissue shell of the long bones, and provides a 
large surface area exposed to circulating fluids. As they are more responsive to 
estrogens, there is usually loss of trabecular tissue late in life (Marieb and Hoehn, 2007).
1.14.4 Calcium homeostasis
Bone tissue serves as a reservoir of calcium and other minerals that are used by other 
tissues of the body. Normal calcium homeostasis occurs when the source of calcium in 
the diet is adequate and when 99 percent of the calcium concentration is found in the 
skeleton and 1 percent is used in a variety of critical life processes. Usually, calcium is 
regulated by complex mechanisms that maintain calcium homeostasis. Inadequate 
calcium intake may lead to an increase in mobilisation of calcium ions and osteoclastic 
development through regulatory hormones, such as parathyroid hormone (PTH) and 
1,25-dihydroxyvitamin D (calcitriol), (Martinez-Reina et al., 2008). However, the 
efficient absorption of calcium gradually declines in later life (Ensrud et al., 2000; 
Ensrud et al., 2000), and during menopause (Nordin, 1997), calcitriol works to reduce 
the effects of intestinal absorption (Insel et al., 2004).
47
1.14.5 Bone markers
Several biochemical bone markers may be used as a measure of either bone formation or 
bone resorption. Plasma bone-specific alkaline phosphatase is a marker of bone 
formation. Serum cross-linked collagen telopeptides, urinary N-telopeptides (NTXs), 
and plasma tartrate-resistant acid phosphatase (TRAP) are markers of bone resorption. 
Bone turnover is a process that results in the release of biochemical markers into the 
circulation, and then possibly into the urine. Potential mechanisms that can bring about 
osteoporosis include decreased bone formation, increased bone resorption, or abnormal 
bone mineralisation (Demers, 1992).
1.14.6 Nutrition and bone
Calcium, phosphate and vitamin D are essential for normal bone structure and function, 
but several other micronutrients play an essential role in bone health and formation, such 
as magnesium, fluoride and vitamins A, D, and K (Baker and Worthley, 2002). 
Insufficient dietary phosphorus is accompanied by acute bone demineralisation and the 
loss of calcium in the urine (Pohlandt, 1994). Magnesium is a co-factor in more than 
300 enzymatic reactions and plays a major role in bone cell function and hydroxyapatite 
crystallization and growth. About half of the body’s magnesium is found in bone (Shils, 
1988); magnesium deficiency may play a role in osteoporosis (Tucker et al., 1999). 
Among adults, about half of the fluoride absorbed each day is deposited into bones and 
teeth. The rate of deposition into bone tissue varies with age and is more efficient in
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young children in order to support skeletal development; fluoride levels can also 
stimulate new bone formation (Medicine, 1997).
1.14.7 Antioxidants and their importance for bone health
Several antioxidant vitamins, such as vitamins E and C, play a significant role in bone 
health (Pasco et al., 2006). Strong biological antioxidants, such as vitamin E, can 
function as a free radical scavenger and limit bone resorption from the effects of 
cytokines (McAlindon and Felson, 1997; Darlington and Stone, 2001), while stimulating 
bone formation in young adults and old mice (Arjmandi et a l , 2002). Also, vitamin E 
has been reported to protect trabecular bone formation from damage, as a result of lipid 
peroxidation (Xu et al., 1995). Antioxidants affect bone health through their action on 
ROS as shown in Figure 1.8.
Oxidative stress may play an important role in bone health, as it has been reported to 
inhibit osteoblastic differentiation in rabbit bone marrow stromal cells (BMSC) and 
calvarial osteoblasts (Bai et al., 2004). Production of free radicals from osteoclasts is a 
normal, physiological function, but this can accelerate the rate of bone turnover. Some 
other risk factors for osteoporosis, such as smoking, hypertension, diabetes and 
malnutrition may be associated with the production of free radicals (Sheweita and 
Khoshhal, 2007). Early in the remodelling sequence, osteoclasts are attracted to a 
quiescent bone surface (Figure 1.9, a).
Both a healthy diet and regular exercise help to maintain good bone health and may 
reduce the risk of osteoporosis (Anderson et al., 1996; Parsons, 2005; Iacono, 2007). 
Understanding the mechanisms of bone growth and bone loss tell us how micro- 
macro/nutrients may be important in maintaining bone health (Figure 1.9, b).
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Figure 1.8 Link between bone health and oxidative stress; animal studies have shown 
that free radicals m ay be involved in osteoclastogenesis and bone resorption. Free 
radicals m ay increase bone resorption through activation o f N F-kB , and several risk 
factors for osteoporosis m ay be associated with increased oxidative stress where, 
generally speaking, levels o f superoxide anion are present (Schreck e t  al. ,  1991; Suda e t  
a l ,  1993).
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Figure 1.9a. Schematic diagrams to show the stages in the rem odelling o f trabecular 
bone; early in the rem odelling sequence, osteoclasts are attracted to a quiescent bone 
surface, (A) & excavate an erosion cavity (B, C). M ononuclear cells smooth o ff the 
erosion cavity (D), which is then a subsequent site for the attraction o f osteoblasts and 
which synthesise an osteoid matrix (E). Continuous new bone m atrix synthesis (F) is 
followed by calcification (G) o f the newly form ed bone. W hen this is complete, lining 
cells once more overlie the trabecular surface (H). (Kanis and M cCloskey, 1997).
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Figure 1.9b. Bone remodelling. 1) Bone Growth: i) Proliferation o f osteoblasts to form 
osteocytes. ii) Uptake o f calcium by osteoblasts and osteocytes. iii) Production o f 
collagen by osteoblasts, d) Calcium and collagen form bone matrix; 2) Bone Loss: i) 
Inhibition o f osteoblasts' proliferation, ii) Reduction o f calcium  uptake, iii) Reduction o f 
Collagen production, d) Increased bone breakdown by osteoclasts.
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1.14.8 Vitamins A, D, and K
Vitamin A is important for bone growth and maintenance because of its effect on 
osteoclasts, which are regulators of a part of bone formation and metabolism, through 
the action of osteoclasts and by gene expression of cathepsin K/OC-2 (Saneshige et al., 
1995). Recent studies suggest that high consumption of retinol in the diet and food 
supplements may be associated with hip fracture among postmenopausal women using 
estrogens. Results showed there was a significant association between women taking 
vitamin A supplements and risk of fracture, than those without (Feskanich et al., 2002). 
Vitamin D is necessary for the absorption and deposition of calcium and phosphorus in 
bones and teeth. It is manufactured in the skin and is also obtained through dietary 
sources. It is therefore important that a balanced amount of vitamin D be taken, because 
an excessive amount is toxic and low levels are associated with hypocalcaemia (Holick, 
2004). There are two sources of vitamin D: Diet and skin biosynthesis (exposure to 
ultraviolet light): See Figure 1.10. Deficiency of vitamin D may be associated with 
secondary hyperparathyroidism (excess production of parathyroid hormone (PTH)) and 
increased bone resorption (Lips, 2001). Vitamin K plays a suitable role in functioning 
osteocalcin, a bone matrix protein. Several reports have shown significant associations 
between low intake of Vitamin K and fracture risk (Braam et al., 2003). Also, some 
clinical research has suggested that adequate vitamin K intake may be associated with 
decreased bone turnover and decreased urinary calcium excretion (Bataille et a l , 1991).
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Figure 1.10 Diagram  o f continuous production o f vitamin D and its m etabolism  and 
regulation for calcium homeostasis and cellular growth; serum calcium  regulated by 
three major hormones: parathyroid horm one (PTH), 1,25-dihydroxyvitamin D and 
calcitonin; UVL—> skin —> 7-dehydrocholesterol —► pre vitam in D —> vitam in D —> 
25(OH) D3 in the liver 25(OH) D 3 l,25(O H )2 D3 + 24,25 (OH)2 D3 in kidney) 
(Holick, 2004).
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1.14.9 Calcium
The first volume of Dietary Reference Intakes, which included calcium, phosphorus, 
magnesium, vitamin D and fluoride, was published in 1997 by the Institute of Medicine 
“Food and Nutrition Board” (Medicine, 1997). After that time, adequate intakes (AIs) 
have been recommended in new policies to cover all stages of life. Consumption of 
high-calcium dairy products, such as milk and yoghurt, is the best way to meet daily 
requirements. Also, the importance of minerals such as calcium, magnesium, 
phosphorus and iron have been linked to mineralisation of bones, serving as co-factors 
to many enzyme systems and sustaining muscle and nerve excitation (Clarkson and 
Haymes, 1995). Additionally, adequate mineralisation has been linked to physical 
activity, as exercise and adequate dietary calcium intakes (around 1,000 mg per day) 
may be required to optimize bone health (Specker and Vukovich, 2007). The amount of 
calcium in the skeleton is about 1kg, with approximately 99% contained in bones and 
teeth. In addition, bone mineral acts as a Ca reservoir for; 1) behaving as a large "ion 
exchanger", and 2) interaction between ions in body fluids and bone.
1.14.10 Influence of trace elements on bone health
Trace elements are present in the human body at very low concentrations < 0.01% , and 
they include copper, zinc, manganese and selenium (Mertz, 1981). Trace elements are 
known to play important roles in bone metabolism and turnover (Okano, 1996). 
However, their roles and function in the prevention of bone loss are not well established
(Strause et al., 1994). Nutritional deficiencies or excess of trace elements can affect 
bone health, whereas some trace elements (copper, zinc, manganese) can promote the 
strength of bone and connective tissues (Rico, 1991). Eberle et al. have reported that 
zinc deficiency supports the development of osteoporosis (Eberle et al., 1999). Growth 
retardation and selenium deficiency have been shown to be associated with impaired 
bone metabolism (a process of resorption by osteoclasts and deposition by osteoblasts in 
which calcium, PTH, vitamin D, growth hormone, steroids, together with several 
cytokines are involved), and osteopenia in second-generation selenium-deficient rats 
(Moreno-Reyes et al., 2001). Bone growth retardation is commonly associated with zinc 
deficiency, since the zinc content of bone decreases with aging, skeletal unloading and 
postmenopausal conditions (Yamaguchi, 1992). Zinc deficiency may play a 
pathophysiological role in the decline of bone metabolism by activating amino acyl- 
tRNA synthesised in osteoblastic cells, which stimulates cellular protein synthesis 
(Yamaguchi et al., 1994). Moreover, zinc inhibits osteoclastic bone resorption by 
inhibiting osteoclast-like cell formation from marrow cells (Kishi and Yamaguchi, 
1994).
p-alanyl-L-histidinato zinc (AHZ), acts on osteoblastic cells and stimulates the 
production of growth factors and bone matrix components from the cells, which prevents 
bone losses. In the main, AHZ prevents the bone-resorping factors-induced osteoclast­
like cell formation from marrow cells, and inhibits osteoclastic bone resorption 
(Yamaguchi et al., 1992). Zinc can directly stimulate the production of insulin-like 
growth factor-1 (IGF-1) from osteoblasts, with an effect on collagen synthesis 
(Yamaguchi and Hashizume, 1994).
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1.14.11 The risk factors for osteoporosis / poor bone health
As a result of demographic changes in the world, the osteoporotic fracture has become 
associated with increased mortality and morbidity (Riggs and Melton, 1995). The 
number of such fractures occurring worldwide in 1990 was estimated to be 
approximately 1.66 million per annum (Kannus et a l , 1996). In some cultures and 
ethnic groups, women are at high risk of developing osteoporoses, and especially so 
when associated with a deficiency of vitamin D and lack of exposure to sunlight (Taha et 
al., 1984). The annual cost to the healthcare system from osteoporotic fracture has been 
estimated at approximately £1.7 billion in the UK, about 13.9 billion € in Europe, and 
about 17.9 billion dollars in the USA (Kannus et a l , 1996). Today, many researchers 
are focussing on the cost of treatment programmes when trying to solve the problem. 
Risk factors can be divided into two groups - major and minor - and can be broadly 
divided into non-modifiable and modifiable (Johnell et a l, 1995). Each part has a 
specific importance with regard to the identification of high-risk patients, as shown 
below in Figure 1.11.
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Low BMD
Smoking
Advanced age
Low body weight
Fem ale sex
Estrogen deficiency
Personal history
M odifiab leAlcoholism -S N o n -M o d ifia b le  I
' ------------------------- Caucasian and Asian race
Oral glucocorticoid
Dementia
Low calcium intake
Poor health /fra ilty
Recurrent fails
Little or no physical activity
Figure 1.11. Risk factors for osteoporotic fractures, (Adapted from National 
Osteoporosis Foundation Physician's Guide to Prevention and Treatm ent o f  
Osteoporosis, Belle M ead, N J Excerpta M edica, Inc. 1998).
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Age is the most important risk factor for osteoporosis, and much research has shown that 
advanced age is a high risk factor for both men and women (Cummings et a l, 1995). 
With regard to gender, the occurrence of hip fractures in women was approximately 
75% higher then in men (Kaufman et al., 2000). BMD is a risk factor for fractures in 
both men and women, which may give a prediction of hip fracture (Kanis et al., 2001). 
A previous history of fractures can be used as a risk factor of osteoporosis, especially 
when a vertebral fracture occurs during a specific period (Johnell et a l, 2001).
Ethnicity is another risk factor; hip fracture among Caucasian women was significantly 
higher when compared with other ethnic groups (Diaz et a l, 1997). Genetic aspects on 
osteoporosis and fractures have also been studied; if  a family member has suffered a hip 
fracture, this may lead to an increase in the incidence for the next generation (Diaz et a l,
1997). Several studies have also shown that physical activity is linked to fracture rate 
(Johnell et a l, 1995). Tobacco smoking is responsible for the decrease in BMD between 
men and women (Jones et a l, 1995). Sunlight is also an important factor, especially 
where reduced exposure to the sun seems to increase the risk of hip fracture (Nordin and 
Morris, 1992).
1.15 Geographical and ecological studies
There is a high incidence of osteoporosis peaking in young and elderly people. In young 
people, it is more frequent in males than in females, but with increasing age there is no 
difference between genders (Farmer et a l, 1984; Maggi et a l, 1991). Clinically
observed fracture rates are lower in black populations, than in Caucasian or Asian 
populations. The incidence of hip fracture in Europe varies considerably from country 
to country, with Sweden being the highest in Europe. The USA population has an 
intermediate risk and African populations have the lowest rate (Daniels et al., 1995). A 
study of osteoporosis has shown that 1 in 3 women and 1 in 12 men over 50 years of age 
have osteoporotic fracture. The United Kingdom incidence for hip fractures is 
approximately 90,000 per annum and >100,000 vertebral fractures per year, with an 
annual cost to the UK of more than £1.7 billion, in addition to £1.6 billion on CHD 
(Torgerson and Dowling, 2001).
1.16 Links between bone health and cardiovascular disease
Low bone mineral density (LBMD) has been reported to be a more reliable indicator in 
the prediction of cardiovascular mortality among older men and menopausal women, 
than blood pressure and serum cholesterol (McFarlane et al., 2004). Some risk factors 
for CVD, such as dyslipidemia, oxidative stress, inflammation, hyperhomocystinemia, 
hypertension and diabetes, as well as menopausal status and advanced age, have been 
associated with increased risk of low bone mineral density (LBMD). An increase of 
LDL and a decrease of HDL cholesterol has been associated with LBMD, which could 
be related to the change in lipid metabolism and which is associated with both bone 
remodelling and the atherosclerotic process. Inflammation plays an essential role in 
both atherosclerosis and osteoporosis, throughout the elevation of plasma homocysteine
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levels that are associated with both CVD and osteoporosis. Nitric oxide (NO) also plays 
a role in osteoblast function and bone turnover (McFarlane et al., 2004).
The importance of trace elements (such as copper, zinc, and magnesium) has been linked 
not only to the quality of life, but also to beneficial effects on bone density (Klevay,
1998). Matrix proteins serve an important function in bone formation and in the 
development of atherosclerosis (Hamerman, 2005). There are a number of matrix 
proteins, such as type 1 collagen, proteoglycan, osteopontin, and osteonectin, which are 
found in bone and vascular matrix components. They play an important role both in 
bone development and in atherosclerosis. Oestrogens can also play a role in both CVD 
and osteoporosis (OP) through their effects on cytokines, such as IL-1, IL-6 and TNFa 
and osteoprotegerin (OPG). The shortage of estrogens induces an increase in these 
cytokines and a reduction in OPG, both of which are involved in the mechanisms of 
bone loss and atherogenesis (Baldini et al., 2005). Cardiovascular and bone health 
present numerous epidemiological challenges and health consequences. In Western 
societies, it is common for the appearance of bone disease and CVD to vary according to 
genetic, nutritional, and physiological factors. Furthermore, many studies show a link 
between a decrease in bone mass and an increase in cardiovascular mortality (Nawroth 
et al., 2003). A diet low in copper can contribute to both osteoporosis and ischemic 
heart disease, and there is an epidemiologic association between these two illnesses 
(Guggenheim et al., 1971). Copper deficiency can be implicated in both cardiovascular 
and bone disease (Klevay, 1998). For a long period of time, scientists have suggested 
that copper metabolism has played a role in coronary heart disease, and also that copper
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deficiency is the only nutrition that; elevates cholesterol, blood pressure and uric acid 
(Klevay, 1993), and decreases osteoblast activity (Baxter et a l , 1953), and human 
osteoporosis (Gillespy and Gillespy, 1991). In addition, many studies have shown that 
supplements with trace elements, such as copper, have an effect on bone density (Strause 
et al., 1994).
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1.17 Objectives of this study
1.17.1 Hypothesis
It is proposed that there are common determinants of vascular and bone health that may 
include dietary factors, inflammation and physical inactivity. Free radicals and 
oxidative stress appear to be important in the pathogenesis of vascular disease and 
perhaps in osteoporotic bone disease.
Zinc, copper and selenium are essential trace elements that are components of 
antioxidant enzymes, which include glutathione peroxides, superoxide dismutase and 
catalase; these may therefore have an important role in both conditions. High levels of 
physical activity are thought to be of benefit for cardiovascular and bone health, 
although they may also affect pro-inflammatory cytokine responses.
In the following series of studies, the relationship has been investigated between dietary 
factors (including macro and micronutrients); physical activity and anthropometric 
measures; and measures of oxidative stress/defences, inflammation, auto-immunity and 
endothelial activation in young female gymnasts, comparing these very active girls with 
normally active, sedentary girls of the same age.
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1.17.2 Study aims
• To set up a validated method for measuring serum GPx and SOD activity using 
enzymatic assays.
• To determine whether measures of serum GPx and SOD, using the 
methodologies developed above, were altered in young females who undertake 
regular intensive exercise, compared to sedentary, adolescent females.
• To measure, using validated methodologies, trace element status (namely, Zn, 
Se, Cu and Mg) in young females who undertake regular, intensive exercise 
compared to sedentary, adolescent females.
• To determine the relationship between body mass index (BMI), physical activity 
levels and dietary intake on serum antioxidants and trace elements, in active and 
inactive adolescent girls.
• To investigate the effect of chronic exercise on markers of inflammation, 
endothelial activation and auto-immunity (sICAM-1, hsCRP, Hsp27 and their 
antibody titres IgM, IgG) using enzyme linked immunosorbent assay in active 
and inactive, adolescent girls.
• To determine if there is an association between risk factors for cardiovascular 
disease, osteoporosis and Hsp27 among these groups, and between age, body 
mass index (BMI) and dietary intake.
• To assess if there were any associations between trace element status and 
antioxidant profiles on markers of bone health in the study population above.
Chapter 2 
Materials and methods
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2. Materials and methods
2.1 Subjects
Subjects were recruited as part of a three-year long investigation into the effects of 
exercise on peak bone mass (PBM) development as previously reported (Nurmi-Lawton 
et al., 2004). Thirty-eight female gymnasts and forty, healthy sedentary females, aged 
8-17 years, were originally recruited from five athletics clubs in the South of England. 
An investigation was conducted as part of a study on antioxidant and trace element 
status, and twenty-five female gymnasts and nineteen, healthy, sedentary adolescent 
females were recruited for the study of markers of inflammation, endothelial activation 
and auto-immunity.
The gymnasts were eligible to join the study if  they trained >10 h/week and regularly 
took part in competitions (at club regional level). The healthy, normally active controls 
were recruited through a database of local General Practices (GPs) in Surrey, South 
England. They were involved in normal activities, including walking to school and 
physical education (PE) classes, for an average 5.6±2.6 h/week (determined by a 
checklist), but not in sports requiring all year training at competition level. In addition, 
anthropometric, physical activity and dietary intake were estimated as described (Nurmi- 
Lawton et a l , 2004) and shown in the appendices. A nutritionist determined the 
anthropometric data from each subject. None of the subjects had evidence of acute 
infection, or inflammation at the time of recruitment, or blood sample collection. The
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ethics approval is also shown in the Appendices.
2.2 Assessments of menarche
Pubertal status was assessed at each measurement occasion, using self-assessment of 
secondary, sexual characteristics. Staging of secondary, sex characteristics according to 
James M. Tanner (Tanner, 1962) has provided a means of assessing sexual development, 
but requires the individual to undress and then be physically examined. It is very 
difficult to collect such personal data in non-medical settings. Self assessment of the 
level of sexual maturation by adolescents has been found to be both valid and reliable, 
and in excellent agreement with physical examination (Morris and Udry, 1980), enabling 
accurate assessment of an individual's own developmental stage according to standard 
photographs by Tanner (Marshall and Tanner, 1969). In the present study, the use of 
adolescent self-staging was deemed most appropriate.
A "Physical Development Assessment Form" was given to every subject/parent along 
with an explanatory letter (Appendix 3). The form contained photographs of the stages 
of development of secondary, sex characteristics during puberty, consisting of the five 
stages of breast development (side and frontal) and five stages of pubic hair 
development. Subjects were instructed to select those pictures which most accurately 
reflected their own stage of development. This method enabled subjects to complete the 
assessment in the privacy of their own home, with the choice of parental guidance. Self- 
assessment was repeated at each stage of data-collection. Subjects were then assigned to
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pubertal groups: pre-pubertal (stage 1), peri-pubertal (stages 2-4) and post-pubertal 
(stage 5 / post-menarche).
2.3 Dietary analysis
The dietary intake of gymnasts and controls was recorded for 7 days at baseline using 
estimated food diaries, which have been shown to have an acceptable, relative validity 
(Bingham et al., 1994). Instructions, including how to estimate portion size, were given 
both verbally and in writing to each subject, or their parent, by a registered dietician. 
Gymnasts were asked to complete the diary on a non-competition week, during the 
athletic training season and controls on a non-holiday week, without changing their 
usual, dietary habits. Subjects (or their parents) were asked to describe the portion sizes 
and write these in the diary. The diaries were analysed using the Diet5 for Windows 
computer package (Robert Gordon University, Aberdeen, UK), which is based on the 
McCance and Widdowson Food Composition Tables (Mark et al., 1992). This allowed 
an estimate of dietary macronutrient (protein, carbohydrate and fat) and micronutrients 
(including selenium, zinc, and water/fat soluble antioxidant).
2.4 Physical activity assessment
The hours of training, changes in training regime of each gymnast, and the type and 
amount of exercise undertaken by controls, were assessed using a questionnaire. The 
Blair score was calculated as described previously (Blair et al., 1985), which gives an
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indication of the individual’s level of physical activity: <33 = very inactive, 33 to <37 = 
inactive, 37 to <40 = moderately active, >40 = active.
2.5 Blood collection and isolation of serum
Non-fasted blood samples were collected from both the controls and gymnasts. Due to 
the recruitment procedure which was used for the gymnasts (via gymnastic clubs who 
only met late afternoon/early evening), blood samples after a 1 2 -hour fast were not 
possible. Control subjects predominantly attended the University of Surrey Clinical 
Investigation Unit (CIU) in the aftemoon/early evening. Collections of samples for the 
gymnast group were carried out before training and out of competition week. Samples 
for the controls were collected during the school holiday. In all cases, they were 
collected around the time that the dietary estimates were obtained. Blood samples 
incubated at 37°C for 30 min and were then centrifuged at 3000g at room temperature to 
obtain serum for analysis of antioxidants and trace elements. Serum samples were 
frozen at -80 °C until they were assayed.
2.6 Reagents
All the standards, concentrated hydrochloric and nitric acid (Spectrosol grade) used for 
trace element determinations were purchased from BDH Chemical Ltd. (VWR 
International Ltd., Leicestershire, UK). The standards used in inductively Coupled 
Plasma-Mass Spectrometry ICP-MS and flame atomic absorption spectrometry AAS
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were as follows: Germanium (1.5ppb); Selenium (lOOOppb); Cupric nitrate (1000 mg/L 
or lOOOppm); Zinc nitrate (15.3mmol/l or lOOOppm); Magnesium nitrate (lmg/ml); 
Lanthanum chloride (0.1% v/v acidified with cone. HC1).
Glutathione peroxidase (GPx) (Cat. no. 703102) and superoxide dismutase (Cat. no 
706002) assay kits were purchased from Cayman Chemical, IDS. Ltd., Ann Arbor, 
USA.
2.7 Determination of selenium, copper and zinc in serum by 
Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)
Serum concentrations of trace elements (selenium, copper and zinc) were measured by 
Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) in samples from both 
gymnasts and healthy, sedentary females, as previously described (Taylor et al., 2003). 
Standards and samples were prepared as described below:
2.7.1 Preparation of standards
Acid pre-cleaned pipettes and glassware were used for the preparation of standards and 
serum samples. All the standards were made in RO water as a diluent.
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Preparation of selenium standards from 0.01 mmol/L stock
79 pi selenium into 100 ml (RO) = 0.01 mmol/L Selenium working stock
Volume of diluent Volume of selenium stock Final selenium conc.
(ml) (ml) (pmol/L)
9.5 0.5 0.5
9.0 1 .0 1 .0
8 . 0 2 . 0 2 . 0
7.0 3.0 3.0
6 . 0 4.0 4.0
Selenium atom = 78.96
Preparation of copper standards from 0.1 mmol/L stock
0.636 ml of the copper nitrate solution in 100 ml diluent.
Volume of diluent 
(ml)
Volume of copper stock 
(ml)
Final copper conc. 
(pmol/L)
9.5 0.5 5.0
9.0 1 .0 1 0
8 . 0 2 . 0 2 0
7.0 3.0 30
6 . 0 4.0 40
Copper atom = 63.55
Preparation of zinc standards from 0.1 mmol/L stock
0.654 ml zinc nitrate solution into 100 diluent.
Volume of diluent 
(ml)
Volume of zinc stock 
(ml)
Final zinc conc. 
(pmol/L)
9.5 0.5 5.0
9.0 1 .0 1 0
8 . 0 2 . 0 2 0
7.0 3.0 30
6 . 0 4.0 40
Zinc atom= 65.39
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2.7.2 Preparation of serum and blanks
Serum samples for selenium, copper and zinc determination were prepared by diluting 
serum (1:50 dilution) in 0.5% nitric acid at room temperature. To diluted serum, 150 pi 
of internal standard Germanium (1 ppm) was added (final concentration of 1.5 ppb) as 
shown below.
Sample type
Internal standard
0 d)
Sample/QC/standards
Gd)
0.5% nitric acid 
(ml)
Blank 150 0 9.85
Serum 150 2 0 0 9.65
Note: For those samples where sample volumes were limited, 100 pi sample was used 
instead of 200 pi and the diluent volume adjusted accordingly. QC refers to quality 
control samples based on previous human assay variations (Amaud et al., 2008).
2.8 Optimal ICP-MS (Thermo-X series) conditions for the analyzer
Instrument parameters Conditions
RF power 1350 W
Noble gas (inner) 0.7 L/min
Auxiliary gas (intermediate) 0.7 L/min
Cool gas flow (outer) 13 L/min
Spray chamber temperature 4 °C
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Once the optimal conditions were set the ICP-MS analyser was switched on to automatic 
mode. The samples were analysed and the final results for trace elements were 
displayed on another out-plot marker, after taking into account the standard curves.
2.9 Determination of magnesium in serum by Flame Atomic 
Absorption Spectrophotometry (AAS) method
Magnesium concentrations in the serum samples of the gymnast and control female 
subjects were measured by Flame Atomic Absorption Spectrometry.
Preparation of magnesium standards from stock 5 mmol/L
12.17 ml of magnesium nitrate solution (1 mg/ml), diluted into 100 ml diluent.
Volume of diluent 
(ml)
Volume of magnesium 
stock (ml)
Final magnesium conc. 
(mmol/L)
9.5 0.5 0.25
9.0 1 .0 0.50
8.5 1.5 0.75
8 . 0 2 . 0 1 .0
7.5 2.5 1.25
Mg atom = 24.31
2.10 Optimal Flame Atomic Absorption Spectrometry conditions for 
the analyser
Conditions used in Flame AAS for the determination of either magnesium.
Magnesium
Lamp current 7m A
Wavelength 285.2 nm
Band pass 0.5 nm
Chart range 20 mV or 50 mV
Chart speed 1 0  mm/min
2.10.1 Procedure for Flame Atomic Absorption Spectrometry
First, the flame was ignited and the chart recorder was started. Standards, controls and 
samples were aspirated automatically into the AAS. After each standard curve, the 
lowest standard was re-aspirated. For a long “run”, the standard curve was aspirated 
after every 10 samples. At the end of the procedure, a line was drawn through baseline, 
or through the lowest standards, and peak heights were plotted for the measurement of 
the samples against the standards.
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2.11 Measurement of serum antioxidant enzymes by enzymatic 
assays
2.11.1 Glutathione peroxidase (GPx) activity assay
The GPx activity was measured indirectly using a coupled reaction with glutathione 
reductase (GR). The assay is based on the oxidation of glutathione (GSSG), produced 
upon reduction of hydroperoxide by GPx, and is recycled to its reduced state by GR and 
NADPH:
R-O-O-H + 2GSH C1'* ► ROH + GSSG + H20  
GSSG + NADPH + H+  ► 2GSH + NADP+
The oxidation of NADPH to NADP+ was accompanied by a decrease in absorbance at 
340 nm and is an indication of GPx activity, since GPx is the rate-limiting factor under 
these conditions. Therefore, the rate of decrease in the A340 was directly proportional to 
the GPx activity in the sample (Paglia and Valentine, 1967).
2.11.2 Buffers used in the GPx assay
All the reagents, including Glutathione peroxidase, superoxide dismutase and buffers 
were supplied by Cayman Chemical Company, Ann Arbor, USA.
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Assay buffer: 50 mM Tris (hydroxymethyl) aminormethane (Tris-HCL) buffer, pH 7.6, 
containing 5mM EDTA was used in the assay and was stable for 2 months stored at 
4 °C.
Sample buffer: Assay buffer containing bovine serum albumen (BSA; lmg/ml).
Positive control: Bovine erythrocyte glutathione peroxidase was supplied with the kit 
and diluted 1:50 prior to use. 10 pi of the supplied enzyme was diluted with 490 pi of 
diluted sample buffer and kept on ice. 2 0  pi of this diluted enzyme is responsible for a 
decrease of 0.051 nm in the absorbance.
Co-substrate mixture: Consisted of lyophilized powder of NADPH, glutathione, and 
glutathione reductase, and was reconstituted with 2 ml of RO water before use.
2.11.3 GPx assay procedure
The serum GPx activity was measured using a commercial assay kit (Cayman GPx kit; 
IDS. Ltd., UK). Briefly, 20 pl/well serum, sample buffer (blank, background or no 
enzyme), positive control or GPx standards, were added to a 96 well microtitre plate. 
Then 50 pi of co-substrate mixture (NADPH, glutathione and glutathione reductase) was 
added to each well and the plate was gently shaken. The total volume of assay in the 
plate was 190 pl/well. The enzymatic reaction was initiated by the addition of 20 pi of 
cumene hydroperoxide to all the wells and the reaction time was immediately noted.
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The plate was shaken for a few seconds to mix and then read in a plate reader (Genesis 
V 3.05) every minute, for 3 minutes, at 340 nm absorbance. All the assays were 
performed in triplicate.
One unit of GPx activity was defined as the amount of enzyme required to cause the 
oxidation of 1 nmol of NADPH to NADP+ per minute at 25 °C.
2.12 Superoxide dismutase (SOD) activity assay
The superoxide dismutase assay uses a tetrazolium salt for the detection of superoxide 
radicals generated by xanthine oxidase and hypoxanthine, as shown below. The SOD 
assay is able to measure Cu/Zn, Mn, and Fe- SOD.
Formazan dyeXanthine + O2
Xanthine oxidase
Tetrazolium SaltH2O2 Uric acid
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2.12.1 Buffers used in the SOD assay
Assay buffer: 50 mM Tris (hydroxymethyl) aminormethane (Tris-HCL), pH 8.0, 
containing 0.1 mM diethylenetriaminepentaacetic acid (DTPA) and 0.1 mM 
hypoxanthine was prepared by adding 3 ml of assay buffer to 27 ml of RO water and 
was stable for 2 months when stored at 4°C.
Sample buffer: 50 mM Tris (hydroxymethyl) aminormethane (Tris-HCL), pH 8.0. This 
buffer consists of (2 ml of sample buffer and 18 ml distilled water). The buffer was 
stable for two month at 4°C.
Radical detector: Tetrazolium salt solution was prepared just before use as follows: 50 
pi of the supplied solution was diluted with 19.95 ml of dilution assay buffer, and 
protected from light.
SOD standard: Bovine erythrocyte SOD (Cu/Zn) was used neat, as supplied.
Xanthine Oxidase: 50 pi of the supplied enzyme was diluted with 19.95 ml of sample 
buffer and stored on ice until ready to be used.
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2.12.2 Standard preparation
0.02 ml of the SOD standard was diluted in 1.98 ml of sample buffer, to obtain SOD 
stock solution for the preparation of the following standards.
SOD Stock 
(ml)
Sample buffer 
(ml)
Final SOD activity 
(U/ml)
0 . 0 0 1 0 . 0 0
0 . 0 2 0.98 0.025
0.04 0.96 0.05
0.08 0.92 0 . 1 0
0 . 1 2 0 . 8 8 0.15
0.16 0.84 0 . 2 0
0 . 2 0 0.80 0.25
2.12.3 Superoxide dismutase assay procedure
Serum total SOD activity was measured using a colorimetric commercial kit (Cayman 
SOD kit; IDS Ltd., UK). All the reagents, except samples and xanthine oxdiase, were 
equilibrated to RT before the start of the assay. Briefly, 200 pi of radical detector was 
added to all the wells. Then 10 pi of samples, standards or sample buffer (background; 
instead of xanthine oxidase) was added to each designated well. Then the reaction was 
initiated by the addition of 2 0  pi of diluted xanthine oxidase and the initial, precise 
reaction noted. The plate was carefully shaken and then incubated for 20 minutes at RT 
for the reaction to develop. The absorbance was read as above at 450 nm.
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One unit of SOD was defined as the amount of enzyme needed to produce 50% 
dismutation of the superoxide radical. SOD activity was expressed as U/ml. All assays 
were performed in duplicate.
2.12.3.1 Calculations and precision
The GPx activity was calculated by subtracting the slope of the blanks from the slope of 
the samples (Figure 2.1). The intra-assay co-efficient of variation CV for the GPx 
stander was 5.7% and the inter-assay CVs was 7.2%. The average serum SOD activity 
was also calculated by subtracting the background absorbance from the samples (Figure 
2.2). According to the equation, SOD activity = sample/slope X (0.23ml/0.01ml) X 
sample dilution. Precision was estimated for SOD standard; the intra-assay co-efficient 
of variation CV was 3.2% and inter-assay CV was 3.7%.
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Activity of Bovine Erythroctye GPx
CO
y = -1 .0 9 6 1 x + 8.4417 
R2 = 0.999
Time (min)
Figure 2.1 Stander curve of linearized glutathione peroxidase.
Superoxide dismutase standard curve
3
2
1
y = 5.813 x + 1.0135 
R2 = 0.9986
0
0.1 0.15 0.2 0.250.050
SOD Activity
Figure 2.2 Stander curve of linearized superoxide dismutase.
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2.13 Measurements of serum C-reactive protein (CRP) by using 
enzyme-linked immunosorbent assay (ELISA)
2.13.1 Reagents and materials
Reagents and antibodies used for CRP measurement were purchased from Dako Ltd., 
Cambridge, UK: CRP standard (Cat. no. X0926); Polyclonal rabbit anti-human CRP 
(Cat. no. A0073); 0.2M Carbonate/ bicarbonate buffer pH9.6; Human, rabbit anti-human 
CRP (Cat. no. P0227)
All buffers and other reagents were obtained from Sigma-Aldrich Ltd., Dorset, UK, 
unless otherwise stated. Bovine serum albumin (BSA), (Cat. no. A3803-10G); Tween- 
20 (Cat. no. P7949), Tetramethylbenzidine dihydrochloride tablets (TMB), (Cat. no. 
T3405); Sulphuric Acid (H2 SO4), 2M Hydrogen peroxide (H2O2), (Cat. no. HI 800/15) 
from Fisher Scientific Ltd., Loughborough, UK.
2.13.2 Preparation of standards
The CRP standards were prepared by serially diluting human CRP standard stock 
(lOOng/ml) 1 in 2 dilutions in PBS-T continuing 0.2% BSA to give the following 
standards: 1.56, 3.125, 6.25,12.5, 25.0 and 50 ng/ml.
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2.13.3 Buffers and solutions used in the CRP assay 
Coating buffer: 0.1 M sodium carbonate bicarbonate, pH 9.6 
Washing buffer: PBS-T containing 0.05% Tween-20.
Blocking buffer: PBS + 1% BSA
0.5 g of bovine serum albumen was dissolved in 50 ml of PBS 
Dilution buffer for diluting serum and standards: PBS-T + 0.2% BSA 
Peroxidase conjugated rabbit anti-human CRP.
Rabbit anti-human CRP was diluted 1 in 2000 (0.325 pg/ml) in dilution buffer 
Phosphate citrate buffer (pH 5)
A stock solution was made of 4.8g citric acid, which was added to 250ml of distilled 
water to make 0.05M citric acid solution.
TMB substrate solution:
One tablet dissolved in 10 ml of 0.05M citrate phosphate buffer pH 5.0 plus 2 pi o f 30% 
H20 2.
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2.13.4 C-reactive protein ELISA procedure
The plate was coated with 50 pl/well polyclonal rabbit anti-human CRP (diluted 1 in 
4000 dilution in 0.1M carbonate/bicarbonate buffer pH 9.6) and incubated overnight at 
4°C. The first three wells were coated with buffer alone as blanks. The following day, 
the plate was washed with washing buffer three times. Then 200 pi of blocking buffer 
was added to each well, and the plate was incubated for 60 minutes at 37°C. The plate 
was washed again as above. 50 pi of samples (1:10) and standards diluted in PBS-T- 
0.2% BSA were added to the wells and incubated for 60 minutes at 37°C. The plate was 
then washed four times with PBS containing 0.05% Tween-20. Then 50 pi of 
peroxidase-conjugated rabbit anti-human CRP was added to the wells, and the plate was 
incubated as above. After the incubation, the plate was first washed three times with 
PBS-T, then once with PBS, followed by two times with 0.05M citrate phosphate buffer 
(pH. 5). The reaction was initiated by the addition of 50 pi of TMB substrate solution 
and then incubating the plate in the dark for 3 minutes. The reaction was stopped by 
adding 12.5 pi of 2M H 2 S O 4 ,  and the plate was then read in micro plate reader (Victor3, 
multilabel, Singapore) at 450 nm.
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2.14 Measurements of human soluble intercellular adhesion 
molecule-1 (sICAM-1) by ELISA
2.14.1 Principal of the assay
This assay employs the quantitative sandwich enzyme immunoassay technique. A 
monoclonal antibody specific for sICAM-1 has been pre-coated onto a microplate. 
Standards, samples, controls, and conjugate are pipetted into the wells and any sICAM-1 
present is sandwiched by the immobilized antibody and the enzyme-linked monoclonal 
antibody specific for sICAM-1. Following a wash to remove any unbound substances 
and/or antibody-enzyme reagent, a substrate solution is added to the wells and colour 
develops in proportion to the amount of sICAM-1 bound. The colour development is 
stopped and the intensity of the colour is measured.
2.14.2 Preparation of serum samples and standards
Serum was diluted 1:20 dilution in RD5-7 diluent. The sICAM-1 standards were 
prepared from sICAM-1 stock standard, which was reconstituted with 1 ml distilled 
water to make a 250 ng/ml of working solution. This was further diluted serially 1 in 2 
dilutions in RD5-7 to give the following standards: 50, 25, 12.5, 6.25, 3.13 and 1.56 
ng/ml.
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2.14.3 Soluble human soluble intercellular adhesion molecule-1 assay 
procedure
The assay kit for sICAM-1 (cat.no. DCD540) was purchased from R&D Systems 
(Abingdon, Oxford, UK). The ELISA assay was performed as follows (Figure 2.3) : 
Briefly; to pre-coat (mouse monoclonal antibody against human ICAM-1) 96 well 
microtitre plate, 100 pi sICAM-1 conjugated HRP polyclonal antibodies were added. 
Then 100 pi of standards (1.56-50 ng/ml), positive control or diluted serum sample, 
were added. The plate was incubated for 1.5 hours on the shaker at RT. After 
incubation, the plate was washed four times with washing buffer (400 pl/well) using an 
auto-washer (ASYS, Hitech gmbh, Austria) and 200 pi of substrate solution (TMB 
containing H2O2) was added to each well. The plate was then incubated in the dark for 
30 minutes at RT. The reaction was stopped by the addition of 50 pi 2M sulphuric acid. 
As before, the optical density was read at 450 nm.. All the assays were performed in 
duplicate. A calibration curve was constructed for the determination of serum sICAM-1 
levels.
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M icrotitre plate coated with m ouse m onoclonal 
antibody.
V 7
Add lOOpl o f  conjugated sICAM-1 HRP to pre­
coated wells with mouse m onoclonal antibody.
V 7
Add lOOpl/well o f diluted standard, control, or 
serum sample, and then incubate for 1.5 hours on a 
shaker at RT.
\ 7
The plate was aspirated and washed four times.
\ 7
Add 200jnl substrate per well and incubate for 30 
minutes.
\ 7
Add 50pl stop solution to each well and read it at 
450 nm for 30 minutes
Figure 2.3 Human sICAM ELISA procedure.
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2.14.4 Calculations and precision
The CRP concentrations were calculated by subtracting the slope of the blanks from the 
slope of samples. Precision was estimated for CRP standard; the intra-assay co-efficient 
of variation CV was from 4.4% to 8.3 and intra-assay co-efficient of variation CV was 
from 6 .0 % to 6 .6 %.
ICAMs and the average of the replicate readings for each standard, control and sample 
were calculated and blank values subtracted. A standard curve was constructed by 
plotting the mean absorbance for each standard on the y-axis against the concentration 
on the x-axis. The precision data for intra and inter-assay co-efficient of variation (CV) 
was 3.6-5% and 6.8-4.4%.
Each assay included positive controls from sera with known antibody titres to Hsp27 and 
negative controls (no antigen i.e. no human recombinant Hsp27 or no serum) on the 
same plate. After correction for the non-specific background absorbance, (subtracting 
the absorbance of un-coated wells from the antigen-coated wells for each sample), the 
results were expressed in optical density units. The precision data for intra and inter­
assay co-efficient of variation (CV) was 3.6-5% and 6.8-4.4% respectively.
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Stander curve of human sICAM-1
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Figure 2.6 A stander curve of soluble intercellular adhesion molecule 1 (sICAM).
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2.15 Heat shock protein 27 antibodies and antigen ELISAs
2.15.1 Reagents and buffers used in the assay
Goat-serum, anti-human IgM (u chain specific) peroxidase conjugated antibody, anti­
human IgG (y-chain specific) peroxidase conjugated antibody, and goat anti-rabbit IgG 
peroxidase conjugate were all purchased from Sigma-Aldrich Ltd., Dorset, UK. Human 
recombinant Hsp27 and mouse monoclonal antibody G3.1, rabbit anti-Hsp27 polyclonal 
antibodies were purchased from Stressgen Inc., Ann Arbor, USA.
Coating buffer; 0.05 M carbonate-bicarbonate coating buffer pH 9.6
159mg of sodium carbonate (Na2C0s) and 293mg of sodium bicarbonate (NaHCOs) was
dissolved into 100ml of distilled water.
Wash buffer: PBS containing 0.05% Tween-20 (PBS-T)
Blocking buffer - 4% goat serum (i)
2.0 ml goat serum was added to 48.0 ml PBS to make 50 ml.
Blocking buffer - 3% BSA (ii)
1.5 g BSA was added to 50 ml PBS to make 50ml.
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2.16 Heat shock protein (Hsp27) IgG and IgM antibody titres assay 
procedure
2.16.1 Coating the plate
50 j_il of recombinant Hsp27 (300 ng) diluted in carbonate coating buffer was added to 
each well, the plate was sealed with a transparent sealer and incubated overnight at 4°C.
2.16.2 Preparation of serum samples
Serum samples were diluted 1:100 in 3% BSA.
2.16.3 Assay Procedure
After overnight incubation, the plate was washed three times with PBS-T, blocked with 
200 pi of 3% BSA for 60 mins at 37°C and then incubated at room temperature for a 
further 30 minutes. The plate was washed again as above and then 50pl/well of diluted 
serum samples were added to both antigen coated and uncoated wells, and the plate 
incubated at room temperature for 30 mins. After incubation and washing, 50 ul of 
peroxidase-conjugated anti-human IgM or IgG antibody, diluted 1:2000, was then added 
into each well. The plate was then incubated again at room temperature for 60 mins.
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After washing with PBS-T for 4 times, 50 pl/well of TMB was added and the plate 
incubated for 15 minutes in the dark for the colour to develop. The reaction was stopped 
by adding 50 pi of 2M HCI solution. The absorbance was read at a wavelength of 
450nm.
2.17 Determination of heat shock protein 27 antigen
2.17.1 Coating the plate
The plate was coated with 100 pi of mouse monoclonal Hsp27 antibody G3.1 (2.5 
pg/ml) diluted in PBS. Afterwards, the plate was covered with sealant and incubated at 
4°C for 18-24 hrs.
2.17.2 Preparation of Hsp27 standards
The standards were prepared by serially diluting human recombinant Hsp27 protein in 
4% goat serum to give the following concentrations: 15, 7.5, 3.75, 1.875, and 0.9375 
ng/ml.
93
2.17.3 Assay Procedure
After the overnight incubation, the plate was washed with PBS-T and then blocked with 200 pi 
of 4% goat serum for 45 minutes at 37°C. It was then incubated at room temperature for 
a further 20 minutes. The plate was washed again as above and then 50 pl/well of 
diluted serum samples were added to both antigen coated and uncoated wells and the 
plate incubated at room temperature for 30 mins. After incubation and washing again, 
50 pi of polyclonal rabbit anti-human Hsp27 antibody, diluted 1:6000 in 4% goat serum, 
was added into each well. The plate was then incubated again at room temperature for 
30 mins. After washing 3 times with PBS-T , 50 pl/well of goat anti-rabbit peroxidase- 
conjugated polyclonal Hsp27 antibody was added and the plate incubated for 30 
minutes. Then the plate was washed again 4 times with PBS-T, after which the TMB 
substrate was added and the plate incubated in the dark for 20 minutes for the colour to 
develop. The reaction was stopped by adding 50 pi of 2M HCI solution and the 
absorbance was read at 450nm.
2.18 Statistics and analysis
Statistical analysis was performed using SPSS (Statistical Program for the Social 
Sciences) (version 15, 2007, SPSS Inc., Waker Drive, Chicago, Illinois). Data are 
expressed as mean ± SEM, unless otherwise stated. Normality of the distribution of 
variables was confirmed using the Kolmogorov-Smimov (K-S) test, and parametric or 
non-parametric tests were applied accordingly. Comparisons of anthropometric and
other data at baseline between gymnasts and controls were performed using independent 
t-test or Mann-Whitney tests. A p < 0.05 was considered to be statistically significant. 
The univariate model was initially used to investigate the association between 
antioxidants and physical activity, and the association between hsCRP, sICAM-1, Hsp27 
antigen, antibody titres and physical activity. Stepwise multiple regression models were 
used to assess which of the confounding variables could influence antioxidant enzyme 
concentrations, and hsCRP and ICAM-1. GPx activity and SOD (concomitantly) were 
entered into the regression equation, with different variables included as potential 
determinants, such as physical activity (mins./week), Se, Zn, Cu status, age, weight and 
height, together with daily intakes of the trace elements (Se, Cu and Zn).
95
Chapter 3 
Altered antioxidant and trace element 
status in adolescent female athletes
96
3 Altered antioxidant and trace element status in adolescent 
female athletes
3.1 Introduction
Reactive oxygen species (ROS) are generated during exercise from several sources 
including leakage from the electron transport chain. These ROS may cause cellular 
damage that may subsequently lead to lipid oxidation, protein de maturation and DNA 
damage (Droge, 2003). Glutathione peroxidase (GPx) and superoxide dismutase (SOD) 
are important plasma antioxidant enzymes that may prevent the potentially deleterious 
effects of ROS. Intracellular concentrations of glutathione may be used as an indicator 
of redox status of the cell (Fang et a l, 2002).
Exercise is reported to enhance the endogenous antioxidant defences (Rousseau et a l, 
2006). Repeated episodes of aerobic exercise have been reported to induce the 
expression of antioxidant enzymes (Ji, 2002). It is unknown whether these adaptive 
mechanisms differ with age. In animal models, reduced glutathione (GSH) appears to be 
an important non-enzymatic antioxidant that plays a critical role in protection against 
oxidative stress induced by exercise (Greathouse et al., 2005). Exercise may be 
associated with increased levels of serum glutathione peroxidase (GPx) activity, and this 
was particularly so when coupled with dietary restriction in an animal model (Aydin et 
al., 2007) and energy restriction in athletes (Rankin et a l, 2006).
Several studies have shown a relationship between the extent of physical activity and 
plasma antioxidant concentrations, including GPx and SOD (Criswell et al., 1993; 
Dekany et al., 2006; Marsh et al., 2006). Dekany et al. have investigated the effects of 
duration and intensity of prolonged physical exercise on markers of oxidative stress and 
have reported that exercise can increase the production of reactive oxygen species 
(Dekany et al., 2006). Hoffman et al. ((2007) investigated the relative effects of versus 
high, intensity resistance exercise on lipid peroxidation. In their study, it was reported 
that the increase in plasma malondialdehyde (MDA) was independent of exercise 
intensity, whilst Pialoux and his colleagues reported that the intensity of exercise and 
exposure to hypoxia may have a cumulative effect on oxidative stress (Pialoux et al., 
2006).
A major problem with these previous studies was the possibility of interference from 
confounding factors, due to differences in dietary intake, including that of trace 
elements. This may be important, as the trace elements selenium, copper and zinc, form 
part of the active sites of the antioxidant enzymes, GPx and SOD, respectively (Fang et 
al., 2002). The principal objective of this current study was to determine whether 
chronic exercise alters the antioxidant status, by comparing adolescent, female gymnasts 
engaged in high intensity physical activity, with sedentary girls, o f the same 
chronological age and at the same stage of puberty. The specific objectives, therefore, 
were to assess their serum levels of the antioxidant enzymes GPx and SOD activity, and 
to determine the association with trace element status, whilst considering age, body size 
and dietary intakes of trace elements.
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3.2 Materials and methods, (see chapter 2)
Serum antioxidants and trace elements were measuered as described in chapter 2.
3.3 Results
3.3.1 Anthropometric characteristic of subjects
The physical activity (PA) and anthropometric data standing height (ST), body mass 
index (BMI), weight (Wt) and mid-arm circumference (MAC) of study subjects are 
shown in Table 3.1 and Figures 3.1 & 3.2. As may have been expected, the gymnasts 
showed 4 fold higher physical activity compared to the controls. Compared with 
healthy, adolescent females, the gymnasts were also shorter, with a lower BMI, mean 
weight, and % body fat as previously reported (Laing et a l, 2002; Filaire et al., 2003). 
These differences were statistically significant (p<0.01).
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Table 3.1 Comparison of anthropometric characteristics of the study subjects
Control
(n=40)
Gymnast
(n=38)
Age (y) 11.31±0.26 11.30i0.34
PA (minutes/week) 338.65i21.87 1256.82i40.81**
ST (m) 1.48i0.02 1.36i0.02**
BMI (Kg/m2) 18.48i0.40 16.76i0.29**
Weight (Kg) 40.97il.54 31.72il.26**
Values are expressed as mean ± SEM. Significance of differences compared to the 
control subjects **p<0.01. PA, physical activity; ST, standing height; BMI, body mass 
index.
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Figure 3.1 Scatter plots showing com parison o f anthropometric characteristics o f 
gymnast group subjects [Scatterplot matrices (SPLOM s) to display a m ultivariate data]. 
Bldxaage, age; Ht, height; Wt, weight; BMI, body mass index; Pam inwk, physical 
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Figure 3.2 Scatter plots showing comparison o f anthropom etric characteristics o f control 
group subjects [Scatterplot matrices SPLOMs, to display a m ultivariate data]. Bldxaage, 
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3.3.2 Dietary and energy intakes
Energy, dietary intake of fat and trace elements determined by food diary at baseline are 
shown in Tables 3.2, 3.3 and Figures 3.3, 3.4, 3.5 and 3.6. Table 3.3 provides the RNI 
(Reference Nutrient Intake) and LRNI (Lower Reference Nutrient Intake) values for the 
UK. The gymnasts consumed significantly less total fat, particularly saturated fat and 
cholesterol, compared to the controls, based on average daily intake baseline record 
(p<0.05). They also had a significantly lower intake of selenium (p<0.05). There were 
no significant differences in energy or dietary antioxidant intake between the two 
groups. The mean dietary intakes of both gymnasts and controls were higher in energy, 
fat, MUFA, PUFA, and Vit. C than reported in the National Dietary Nutritional Survey 
(NDNS) (Gregory et al., 2000). Furthermore, mean dietary SFA, cholesterol and zinc 
were higher in the gymnasts and lower in the control group compared with data from 
the NDNS (Gregory et al., 2000). Overall, 22.1% of the subjects were below the LRNI 
for Se intake and 28.7% for Zn intake. This percentage value rose to 81.4% for all 
subjects below the RNI for Se intake and for all subjects below the RNI for Zn intake.
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Table 3.2 Energy and macronutrient intakes of controls and gymnasts groups of subjects
Dietary intakes Control(n=40)
Gymnast
(n=38)
NDNS; 4-18years 
(All ages, females)^
Energy (Kcals) 1819.02±36.80 1695.73±60.37 1582±357
Fat (g) 74.25±1.71 67.77±2.90** 63.1±17.09
SFA 28.15±0.72 24.68±1.21** 25.2±7.42
MUFA 24.27±0.60 2 2.58±0.98 20.6±5.90
PUFA 12.61±0.47 12.30±0.62 9.3±3.51
Choi (mg) 179.72±6.96 156.68±8.75** 169±71
Values are expressed as mean ± SEM. Significance of difference compared to the 
controls; **p<0.01. NDNS, Nutrition Diet and Nutrition Survey (2000), ^values are 
expressed as mean ± SD; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; 
PUFA, polyunsaturated fatty acid; Choi, cholesterol.
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Figure 3.3 Scatter plots showing energy and m acronutrient intakes o f  gym nast group o f  
subjects [Scatterplot matrices SPLOMs, to display a m ultivariate data]. Ener, energy; 
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Table 3.3 Micronutrient intakes of controls and gymnasts groups of subjects
Dietary intakes Control(n=40)
Gymnast
(n=38)
NDNS; 4-18years 
(All ages, females) ^ RNI LRNI
Se (mcmol/L) 38.61±1.93 32.24±2.12** _ _ _ 45 25
Zinc (mg) 6.51±0.18 5.92±0.26 5.7±1.71 9.0 5.3
Vit C (mg) 94.14±10.38 83.88±10.14 76.1±58.32 40 9
Vit E (mg) 5.10±0.39 5.06±0.48 7.8±4.53 — —
Values are expressed as mean ± SEM. Significance of difference compared to the 
control; **p<0.01. NDNS, Nutrition Diet and Nutrition Survey (2000), Values are 
expressed as mean ± SD; Se, selenium; Zn, zinc; Vit, vitamins; RNI, reference nutrient 
intake; LRNI, lower reference nutrient intake.
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3.3.3 Serum antioxidant enzymes and trace element concentrations
As shown in Table 3.4, and Figures 3.7 and 3.8, serum GPx concentrations were 
significantly higher in the gymnast group compared to the controls (156.92±11.07 vs. 
125.14±8.79 U/mL; p<0.05). Serum selenium concentrations were also significantly 
higher in the gymnasts (0.89±0.03 vs. 0.81±0.03 pmol/L; p<0.05) despite having a 
significantly lower dietary intake of the nutrient. In contrast, serum SOD concentrations 
were lower in the gymnast group (7.23±0.41 vs. 8.57±0.385 U/mL; p=0.05). There was 
no significant difference in serum zinc or copper between the two groups.
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Table 3.4 Serum antioxidant enzymes and trace element concentrations in controls and 
gymnasts groups
Serum antioxidant
Control
(n=40)
Gymnast
(n=38)
GPx (U/mL) 125.14±8.79 156.92±11.07*
SOD (U/mL) 8.57±0.38 7.23±0.41*
Se (mcmol/L) 0.81±0.03 0.89±0.03*
Zn (mcmol/L) 10.32±0.28 10.86±0.39
Cu (mcmol/L) 14.38±0.42 14.50±0.50
Values are expressed as mean ± SEM. Significance of differences compared to control 
group; *p<0.05. GPx, glutathione peroxidase; SOD, superoxide dismutase; Se, selenium; 
Zn, zinc; Cu, copper.
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3.3.4 Univariate analysis
The association between anthropometric measurements, dietary intakes with serum 
antioxidant enzymes (GPx and SOD), and trace elements (Se, Cu, and Zn), were 
assessed using Pearson product moment correlation co-efficients (Table 3.5). The 
results showed a significant, strong, positive association between levels of physical 
activity and serum zinc concentration in gymnasts and the control subjects 
(0.05<p<0.01). No other associations were observed between anthropometric 
measurements and antioxidant enzymes, or any other trace element measured, either in 
gymnasts or in the control subjects (Table 3.5), except for age, however, which also 
showed a significant, positive association with serum zinc concentration for the 
gymnasts alone.
In controls, there were significant, negative correlations between serum selenium 
concentrations and dietary total energy intake and carbohydrates (0.05<p<0.01). In the 
gymnasts (Table 3.5), significant, positive correlations were observed between serum 
SOD and dietary monosaturated and polyunsaturated fats (p<0.05). Cholesterol intake 
correlated negatively with serum copper concentration.
However, no significant correlations were observed between dietary micronutrients (Zn, 
Se, Vitamins A, C, and E) and antioxidant enzymes, or the trace element concentrations 
measured in the healthy controls or adolescent gymnasts (Table 3.5).
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3.3.5 Multiple regression analysis
To take account of potentially confounding variables, stepwise regression analysis 
was used, in which glutathione peroxidase was entered into the regression equation 
as the dependent variable; weight, height, physical activity, selenium, copper, zinc 
status and dietary intake o f trace elements were entered as independent variables. 
The results revealed that physical activity was the strongest predictor o f GPx activity, 
contributing approximately 7% of the variation in GPx activity [GPx activity =107.6 
+ 0.04 x PA (mins/week); with an adjusted R =0.01]. Physical activity also 
explained 7.4% of the variation in SOD activity [SOD activity = 9 + (0.001) x PA 
(mins/week), with an adjusted R =0.07]. Table 6 shows the partial correlation co­
efficients between GPx activity and physical activity (p<0.033) and the inverse 
relationship between SOD activity and physical activity (p<0.01). After adjustments 
for weight, height and BMI, these confounding variables remained significant.
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Table 3.6 Partial correlation co-efficients between antioxidant enzymes and physical 
activity (PA m/wk).
Correlation co-efficients p Co-efficient p-value
SOD r = -.248 .033
GPx r = .295 .010
P Co-efficient was derived from univariant analysis. GPx, glutathione peroxidase; 
SOD, superoxide dismutase.
/
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3.4 Statistical analysis
Statistical analysis was performed using SPSS (Statistical Program for the Social 
Sciences) (version 15, 2007, SPSS Inc., Waker Drive, Chicago, Illinois). Data are 
expressed as mean ± SEM, unless otherwise stated. Normality o f the distribution o f 
variables was confirmed using the Kolmogorov-Smimov (K-S) test, and parametric 
or non-parametric tests were applied accordingly. Comparisons of anthropometric 
and other data at baseline between gymnasts and controls were performed using an 
independent t-test or Mann-Whitney tests. A p < 0.05 was considered to be 
statistically significant. A univariate model was initially used to investigate the 
association between antioxidants and physical activity. Stepwise multiple regression 
models were used to assess which of the confounding variables would be able to 
influence antioxidant enzyme concentrations. GPx activity and SOD were 
concomitantly entered into the regression equation, with the following variables 
included as potential determinants; physical activity (mins/week), Se, Zn, Cu status, 
age, weight and height, together with daily intakes of the trace elements (Se, Cu and 
Zn).
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3.5 Discussion
Whilst physical activity is associated with increased oxygen consumption and 
oxidative stress, and is accompanied by the acute release o f free radicals and 
consumption of antioxidants, studies have demonstrated that chronic, physical 
activity may be associated with a compensatory induction o f the antioxidant defence, 
that includes the antioxidant enzymes GPx and SOD (Abemethy et at., 1990). Most 
previous studies have not taken into account the possibility o f confounding factors 
that include anthropometric differences and dietary intake, that are also likely to vary 
between active and less active subjects. This present studyhas attempted to take 
these factors into account.
3.5.1 Associations between trace element status, anthropometric 
measures and serum antioxidant enzyme concentrations
Serum GPx was higher in gymnasts, compared to the control group. Whilst this may 
in part be explained by an induction o f this enzyme as a compensatory mechanism, in 
response to the chronic exposure to increased levels of radicals, the study’s findings 
for serum SOD are not entirely consistent with this hypothesis and so there may be 
other explanations for this. The current study has previously reported that in a large, 
mixed gender sample, serum concentrations o f several trace elements may be 
affected by dietary intake, physical activity and anthropometric factors, including 
adiposity (Ghayour-Mobarhan et al., 2005). It has been reported that dietary 
deficiency of copper and zinc may be associated with decreased tissue levels of
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SOD, possible peroxidative cellular damage and increased ROS generation 
(Hammermueller et al., 1987). Whilst gross dietary deficiency is an unlikely finding 
in these healthy groups of girls, previous studies have reported that female athletes, 
in their desire to lose weight, may have an insufficient dietary intake (Hinton et al., 
2004).
3.5.2 Associations between serum antioxidant enzymes and extent 
of physical activity
The duration o f habitual, physical activity was clearly different between the 
gymnasts and controls (p<0.01) and it is likely that the intensity of activity was also 
greater for the gymnasts. Physical activity was a significant determinant o f serum 
GPx concentrations, even after correction for several anthropometric variables. 
There were also significant, positive associations between levels o f physical activity 
and serum zinc in both the gymnasts (r = 0.328, p<0.05) and controls (r = 0.390, 
p<0.01). These data are consistent with previous reports, where zinc and copper 
intakes did not affect the biochemical indices measured. Athletes engaging in long­
distance or high-impact aerobic modalities have been reported to have higher indices 
of antioxidant protection (erythrocyte zinc, superoxide dismutase activity and 
metallothionein), than those undertaking short-distance, low-impact activities, 
suggesting that there is adaptation of the antioxidant capacity, in response to the 
specific training (Koury et al., 2004). However, some research has shown similar 
findings to this study. Zembron and his colleagues have showed significant 
reductions in serum SOD activity, and elevations in other antioxidant enzymes,
(including GPx and catalase (CAT), in response to muscle damage associated with 
exercise (Zembron-Lacny et al., 2008). Results of this study indicate that the serum 
antioxidant enzyme concentrations may be dependent on the amount and intensity of 
physical activity undertaken. These findings are in agreement with the results of 
Covas et al., who also showed that serum antioxidant enzymatic activity was directly 
related to the physical activity in females (Covas et al., 2002). Whilst this research 
has focussed on the chronic effects of physical activity, there are also acute effects of 
exercise. Erythrocyte GSH levels have been reported to increase during extreme 
exercise, while there was a decrease in serum SOD activity (Machefer et al., 2007). 
In elite ironman tri-athletes, significantly lower levels of serum malondialdehyde 
(MDA), a marker o f oxidative stress have reported. This was associated with higher 
serum concentrations of GPx and CAT; however, serum GPx concentrations were 
found to be higher in half o f the ironman tri-athletes, who were also found to have 
higher serum MDA concentrations and significantly lower concentrations o f serum 
GPx, SOD, and CAT activity. Therefore, the relationship between physical activity, 
plasma and erythrocyte antioxidant levels is complex, being dependent on the 
intensity, duration and chronicity of the exercise.
In the present study, a significant relationship was found between serum antioxidant 
enzymes, serum trace elements and dietary factors, which included monounsaturated 
fatty acids, polyunsaturated fatty acids and cholesterol. It has previously been 
proposed that cholesterol, monounsaturated fatty acid (MUFAs) and polyunsaturated 
fatty acid (PUFAs), may be affected by levels of physical activity (Squali Houssaini 
et al., 2001; Gordon et al., 2008). Findings from this study show that the gymnasts
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had a higher reported dietary intake of MUFAs and PUFAs and the intake in this 
group was strongly related to serum SOD activity; however, it is not possible to infer 
a causative effect.
3.6 Conclusion
Research from the present study has found that young, female gymnasts have an 
altered serum antioxidant enzyme profile, compared to their less physically active 
peers (25% higher GPx and 16% lower SOD). This appears to be partly related to 
the degree o f physical activity and does not appear to be related to their dietary 
antioxidant intake, but may be affected by dietary macronutrient intake, including 
dietary fibre, monounsaturated fatty acid (MUFAs) and polyunsaturated fatty acid 
(PUFAs). The changes in antioxidant status may be as a compensatory response to 
chronic exposure to increased levels o f free radicals released during exercise, and it 
is unclear as to what extent they may impact on performance. The type, intensity, 
and duration of exercise, and perhaps the activity of the xanthine dehydrogenase 
(XD) / xanthine oxidase (XO) system, may also affect serum GPx and SOD 
concentrations (Vina et a l, 2000).
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Chapter 4 
Markers of inflammation, endothelial 
activation and auto-immunity in 
adolescent female gymnasts and 
controls of the same age
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4 Markers of inflammation, endothelial activation and
autoimmunity in adolescent female gymnasts and controls of 
the same age
4.1 Introduction
Physical activity is associated with reduced serum concentrations of inflammatory 
markers (Kasapis and Thompson, 2005), including C-reactive protein (CRP) (Majka 
et al., 2009), that appears to be dependent on the type and degree o f exercise taken 
(King et al., 2003), together with genetic factors (Shen and Ordovas, 2009). Athletes 
have also been reported to have better endothelial function than sedentary controls 
(Franzoni et al., 2004), although prolonged, brisk exercise is also reported to 
transiently raise markers of endothelial activity, such as ICAM-1 and E-selectin 
(Bartzeliotou et al., 2007).
Reactive oxygen species (ROS) are generated during exercise from several sources, 
including leakage from the electron transport chain. These ROS may cause cellular 
damage, which may subsequently lead to lipid oxidation, protein de-naturation or 
DNA damage (Droge, 2002). However, exercise is also reported to enhance the 
endogenous antioxidant defences (Rousseau et al., 2006). For example, repeated 
episodes of aerobic exercise have been reported to induce the expression of 
antioxidant enzymes (Ji, 2002), and several studies have shown a relationship 
between plasma antioxidant concentrations and the extent o f physical activity
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undertaken (Dekany et al., 2006). Furthermore, Pialoux and his colleagues have 
reported that the intensity of exercise and exposure to hypoxia, may have a 
cumulative effect on oxidative stress (Pialoux et al., 2006), and that although 
antioxidant defences are enhanced in elite athletes, this does not allow sufficient 
buffering for them to counter-balance the over-production o f free radicals during 
exercise (Pialoux et al., 2009). The potential, damaging effects of reactive oxygen 
species can be partially reversed by molecular chaperones, such as heat shock protein 
27 (Hsp27), which may be involved in a process of protein re-naturation (Ferns et ah, 
2006). However, during this process, the chaperone molecules appear to be altered 
in a way that may render them antigenic (Wick et al., 2004).
The principle objective of this current study was to determine whether chronic 
exercise alters markers of inflammation, endothelial activation and auto-immunity by 
comparing adolescent, female gymnasts, engaged in high intensity physical activity, 
with sedentary girls of the same age. Using this young age group o f subjects 
removed the potential confounding effects of existing vascular disease. The specific 
objectives were to assess their serum levels o f CRP, sICAM-1 and Hsp27 antigen 
and antibodies, and to determine their association with age, adiposity and dietary 
intakes o f macro and micro-nutrients.
C-Reactive Protein (CRP) - discovered in 1930 in the serum of patients with acute 
inflammation - is the acute phase protein in humans, which acts as an important 
mediator of immune host defence (Pepys and Hirschfield, 2003; Black et al., 2004). 
The human CRP is synthesised as a 206 amino acid polypeptide (Lei et al., 1985;
Thompson et al., 1999). It is mainly produced by the liver in response to pro- 
inflammatory conditions, or in fat cells. Normal baseline levels of circulating CRP 
are low, but may increase 10,000-fold within hours of inflammation, induced by 
infection or injury (Shrive et al., 1996). CRP binds to phosphocholine on microbes 
that are a constituent of the wall of many bacterial and fungal cells (Thompson et al., 
1999). CRP also binds the membrane of injured cells, together with nuclear 
components of necrotic and apoptotic cells (Gershov et al., 2000; Chang et al.,
2002). The physiological role of CRP is unclear, although these activities suggest 
that CRP functions as an anti-bacterial protein that aids in the clearance o f damaged 
and apoptotic cells. CRP has received attention as a potential, predictive biomarker 
for several pathological conditions, including cardiovascular disease, type II 
diabetes, and stroke (Frank and Hargreaves, 2003). Therefore, levels above 2.4 mg/1 
may be associated with coronary risk and less than 1 mg/1 conceded as a normal 
level. The physiological level is 0.5 to 2 mg/L.
Intercellular Adhesion Molecule 1 (ICAM-1), also known as CD54, is a 
transmembrane glycoprotein that plays a key role in leukocyte migration and 
activation (Hogg et al., 1991; Witkowska and Borawska, 2004). Human ICAM-1 
contains five Ig-like domains in its extracellular domain (ECD) and associates into 
non-covalently linked dimers (Staunton et al., 1988; Reilly et al., 1995). Within the 
ECD, human ICAM-1 shares 53% amino acid sequence identity with mouse and rat 
ICAM-1. The principal binding partners o f ICAM-1 are the leukocyte integrants 
(LFA-1 (CDlla/CD18)) and Macrophage-1 antigen (Mac-1 (CDllb/CD18)) (Hyun 
et al., 2009). At sites o f inflammation, ICAM-1 is up-regulated on endothelial and
epithelial cells, where it mediates the adhesion and migration o f leukocytes 
expressing activated LFA-1 and Mac-1 (Dietrich, 2002; Forbes et al., 2006). ICAM- 
1 ligation prolongs antigen presentation by dendritic cells and promotes T cell 
proliferation and cytokine release (Camacho et al., 2001; Lebedeva et al., 2005). 
ICAM-1 activation also participates in angiogenesis, wound healing, and bone 
metabolism (Lavigne et al., 2005; Langston et al., 2007). Soluble ICAM-1 has been 
reported in serum, cerebrospinal fluid, urine, and bronchoalveolar lavage fluid 
(Rothlein et al., 1991; Melis et al., 2003). Elevated levels of sICAM-1 in serum are 
associated with cardiovascular disease, type 2 diabetes, organ transplant dysfunction, 
oxidant stress, abdominal fat mass, hypertension, liver disease and certain 
malignancies (Kang et al., 2005; Benson et al., 2007). ICAM-1 promotes 
angiogenesis and serves as an indicator of vascular, endothelial cell activation or 
damage (Gho et a l,  1999). Physiologically, ICAM-1 concentration in plasma or 
serum has a range of 200-300 mg/ml.
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4.2 Materials and methods (See chapter 2)
sICAM, hsCRP, HSP27 and HSP27 antibody titres were measured by elisas as 
described in chapter 2.
4.3 Results
4.3.1 Comparison between anthropometric and demographic 
characteristic, dietary and energy intakes.
The physical activity (PA) and anthropometric data of the subjects’ height, body 
mass index (BMI), weight (Wt), skin fold fat, mid-arm circumference and age, are 
shown in Table 4.1, Figure 4.1 and 4.2. As may have been expected, the gymnasts 
showed a 4-fold higher physical activity, compared to controls. Compared with 
healthy, adolescent females, the gymnasts were also shorter, with a lower BMI, mean 
weight, and % body fat as previously reported (Laing et al., 2002). These 
differences were statistically significant.
Energy and dietary intake of fat and trace elements, determined by food diary at 
baseline, are shown in Table 4.1. The gymnasts consumed significantly less total fat, 
particularly saturated fat and cholesterol, compared to the controls, based on average 
daily intake baseline record (p<0.0001). They also had a significantly lower intake
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of selenium (p<0.0001). There were no significant differences in energy or intake of 
dietary antioxidants (vitamins A, C and E) between the two groups.
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Table 4.1 Comparison o f demographic and anthropometric characteristics and dietary 
intakes derived from 7 day food diaries in controls and gymnasts.
Variable Controls Gymnasts
Age (y) 12.0±0.46 13.0±0.70
PA (mins/ week) 304.0±31.21 1308.6±38.06***
Height (m) 1.5±0.03 1.4±0.02
Weight (Kg) 42.6±3.10 34.0±1.44**
BMI (Kg/m2) 19.2±0.77 17.0±0.34**
SFF (%) 23.5±0.77 18.0±0.51***
MAC (cm) 23.6±0.73 21.9±0.37*
M acronutrients
Energy (Kcal) 1822.5±66.29 1740.5±79.77
CHO(g) 246.7±12.27 237.0±11.14
Fat (g) 74.7±2.94 69.5±3.99***
Protein (g) 56.7±2.42 56.4±2.26
SFA (g) 28.8±1.11 25.7±1.61***
MUFA (g) 23.8±1.07 22.9±1.32
PUFA (g) 11.5±0.65 12.4±0.85
Chol (mg) 170.7±13.48 163.6±10.55***
M icronutrients
Se (mg) 36.1±1.36 34.0±2.76***
Zinc (mg) 6.2±0.27 5.9±0.30
Vitamin A 635.3±87.13 727.7±88.22
Vit C (mg) 85.8±11.85 86.5±14.23
Vit E (mg) 4.9±0.67 5.0±0.54
Values are expressed as mean±SEM. Significance of difference compared with the 
controls; *P<0.05, **P<0.01, ***P<0.0001. PA, physical activity; BMI, body mass 
index; SFF, skin fold fat; MAC, mid-arm circumference; CHO, carbohydrates; SFA, 
saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty 
acid; Chol, cholesterol; Se, selenium; Zn, zinc; Vit, vitamins.
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Gymnast
bldxaage ht wt bmi skfofatp mac paminwk
Figure 4.1 Scatter plots showing a positive relationship betw een dem ographic and 
anthropom etric characteristics in gym nast groups o f  subjects [Scatterplot m atrices 
SPLOM s, to display a m ultivariate data]. Pam inw k, physical activity/m inute/w eek; 
BM I, body m ass index; Skfofatp, skin fold fat; M AC, m id-arm  circum ference; W t, 
weight; Ht, Height; B ldxaage, age.
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Figure 4.2 Scatter plots show ing a positive relationship betw een dem ographic and 
anthropom etric characteristics in control groups o f  subjects [Scatterplot m atrices 
SPLOM s, to display a m ultivariate data]. Pam inw k, physical activity/m inute/w eek; 
BM I, body m ass index; Skfofatp, skin fold fat; M AC, m id-arm  circum ference; W t, 
weight; Ht, Height; Bldxaage, age.
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4.3.2 Biochemical data
Serum sICAM was significantly higher in the gymnasts compared to the sedentary 
girls (0.29±0.015 versus 0.23±0.010 mg/L, mean ± SEM p<0.01), whilst serum 
hsCRP concentrations were significantly lower (0.49±0.03 versus 1.38±0.19 mg/L, 
mean ± SEM p<0.0003) Table 4.2, Figure 4.3 and 4.4. These differences remained 
significant after adjustment for body weight and height (ANCOVA, p<0.005). No 
significant differences were observed in concentrations of Hsp27 antigen and 
antibodies (IgG and IgM).
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Table 4.2 Serum hsCRP, sICAM-1, and Hsp27 antigen and antibody titres in controls
and gymnasts.
Biochemical Variable Controls(n=19)
Gymnasts
(n=25)
sICAM (mg/L) 0.23±0.01 0.29±0.015**tt
hsCRP (mg/L) 1.38±0.19 0.49±0.03***n t
Hsp27 (ng) 7.0±1.80 7.07±1.94
Hsp27 IgM antibody titres (nm) 0.43±0.06 0.38±0.03
Hsp27 IgG antibody titres (nm) 0.14±0.01 0.13±0.02
Values are expressed as mean±SEM; ANOVA significant differences **P<0.01, 
***P<0.0003; ANCOVA adjusted for height and weight ^P<0.005; W P<0.0002, 
compared to the gymnasts; sICAM, intercellular adhesion molecule-1; hsCRP, C- 
reactive protein; Hsp27, heat shock protein 27; nm, absorbance at 450nm.
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Figure 4.3 Scatter plots show ing a positive relationship betw een biochem ical 
variables in gym nast groups o f  subjects [Scatterplot m atrices SPLOM s, to display  a 
m ultivariate data]. sICAM , intercellular adhesion m olecule-1; hsCR P, C-reactive 
protein; Hsp27, heat shock protein 27.
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sICAM hsCRP Hsp27 Hap27lgG Hap27lgM
Figure 4.4 Scatter plots showing a positive relationship betw een dem ographic 
biochem ical variables in control groups o f  subjects [Scatterplot m atrices SPLO M s, 
to display a m ultivariate data]. sICAM , intercellular adhesion m olecule-1; hsC R P, 
C-reactive protein; Hsp27, heat shock protein  27.
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4.3.3 Univariate analysis
The association between anthropometric and demographic measurements, dietary 
nutrients and serum biochemical measures of inflammation (hsCRP), endothelial 
activation (ICAM-1), response to cell stress (Hsp27 antigen and Hsp27 antibodies), 
were assessed using Pearson product moment correlation co-efficients (Table 4.3). 
The results showed a significant, negative association between levels of dietary 
factors (fat, SFA, and MUFAs) and ICAM-1 in gymnasts (p<0.05). A significant 
association was also observed between dietary Se and Hsp27 IgG antibody titres 
(p<0.05).
In the controls, there was a significant, positive correlation between total dietary 
PUFAs and Hsp27 IgM antibody titres (p<0.05), see Table 4.3. Significant, positive 
correlations were also observed between height and Hsp27, between age and Hsp27 
IgG, respectively (p<0.05), and between physical activity and Hsp27 IgM; negative 
correlations related to Hsp27 IgG concentrations (p<0.05, respectively). Age was 
positively associated with Hsp27 antigen concentrations and Hsp27 IgG levels 
(p<0.05, respectively). Dietary fat was positively related to serum sICAM-1 
concentrations (p<0.05). No significant correlations were found between dietary 
micronutrients (Zn, Se, Vitamins A, C, and E) and dietary trace element intake in the 
healthy controls, or adolescent gymnasts; see Table 4.3.
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Partial correlation analysis was used to explore the relationship between 
demographic and dietary factors and biochemical parameters in the gymnast and 
control groups separately; see Table 4.4. Preliminary analyses were performed to 
ensure that there was no violation of the assumptions o f normality, linearity and 
homoscedasticity. In the controls, there was a significant, positive, partial correlation 
between dietary fat and serum sICAM-1 [r = 0.46, p<0.05]. A positive, partial 
correlation was also observed between dietary factors (carbohydrate and zinc) and 
Hsp27 IgG antibody [r = 0.60, p<0.05; r = 0.69, p<0.05], and between Hsp27 and 
PUFAs [r = 0.74, p<0.05].
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4.3.4 Association between markers of cardiovascular disease, dietary 
fats and anthropometries
To take account of potentially confounding variables, stepwise multiple regression 
analysis was used, where hsCRP, sICAM-1, Hsp27, IgM, and IgG were entered as the 
dependent variable; physical activity, dietary factors (SFA, MUFAs, PUFAs, and Choi) 
and anthropometric measurements (weight, height or BMI), were then entered as 
independent variables; see Table 4.5. The results showed that physical activity was the 
most significant predictor of hsCRP, contributing approximately 18.5% of the variation 
(p<0.002). Weight explained 20.5% of the variation in sICAM-1 concentration 
(p<0.001). Dietary SFA explained 14.8% of the variation in Hsp27; 21.3% of the 
variation in serum Hsp27 was explained by SFA with Height (p < 0.03; p < 0.001, 
respectively). Dietary PUFA intake explained 11.1% of the variation in Hsp27 IgM
(p<0.02).
When BMI was entered into the equation (Table 4.5), the results showed that body mass 
index was also the most significant predictor of hsCRP, contributing approximately 
19.1% of the variation (p<0.002); 29% of the variation in serum hsCRP could be 
explained by both BMI and PA (p<0.001), and PA accounted for 10.2% of the variation 
in sICAM-1 (p<0.02).
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Table 4.5 Association between marker of cardiovascular disease (hsCRP, ICAM-1, 
Hsp27, and IgM antibody titres) and physical activity, BMI, weight, height, dietary fats in 
gymnasts and controls combined.
Variables R2 P value
Serum hsCRP
PA (minutes/week) 0.185 0.002
BMI(Kg/m2) 0.191 0.002
BMI, PA (minutes/week) 0.290 0.001
Serum ICAM-1
PA (minutes/week) 0.102 0.02
Weight (Kg) 0.205 0.001
Serum Hsp27
SFA 0.148 0.03
SFA, Height (m) 0.213 0.001
SFA, PUFA 0.482 0.001
Serum Hsp27 IgM titres
PUFAs 0.111 0.02
Independent variable entered into the regression equation as variables SFA, MUFA, 
PUFA, PA, BMI, weight, and height; (ANOVA). PA, physical activity; BMI, body mass 
index: SFA, saturated fatty acid; PUFAs, polyunsaturated fatty acid.
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4.4 Discussion
This study has attempted to investigate the impact of chronic intensive exercise on 
markers of inflammation (hsCRP), endothelial activation (sICAM-1) and auto-immunity 
(Hsp27 antigen and antibody concentrations). The observation of young, female 
gymnasts, alongside a group of normally, active girls of the same age, meant that the 
likelihood of confounding effects of co-existing cardiovascular disease was minimised. 
However, it is known that there are a number of other potential confounding factors 
which affect the biochemical parameters measured, including adiposity and dietary 
intake; appropriate corrections were therefore taken into consideration for the final 
analysis. Few previous studies have assessed dietary intake in the detail undertaken by 
the current study and previous research has not investigated the impact of physical 
activity on serum Hsp27 and its antibody titres.
4.4.1 Effects of physical activity on hsCRP concentrations
Serum hsCRP concentrations have previously been associated with an increased 
morbidity and mortality from cardiovascular disease (Koenig et al., 1999). When 
compared with several other markers of vascular risk, hsCRP was found to be the 
strongest, independent predictor of CV risk (Ridker et al., 2001) and of other conditions 
predisposing to CVD, including diabetes mellitus and altered autonomic tone (Freeman et 
al., 2002; Hamaad et a l , 2005). Serum CRP concentrations are positively associated 
with weight and fasting glucose, and inversely related to HDL cholesterol concentrations
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(Piestrzeniewicz et al., 2007). This study has found that serum hsCRP concentrations 
were significantly lower in the young female gymnasts compared to the sedentary 
females and this remained after correction for anthropometric measures of adiposity. 
Cross sectional studies have reported that physical activity is negatively associated with 
hsCRP concentrations, (Geffken et al., 2001) and that the degree of the effect varies with 
ethnicity (Majka et al., 2009). Intervention studies in adults have reported that physical 
activity can reduce serum hsCRP levels in individuals with and without cardiovascular 
disease (Merrill et al., 2008).
A number of studies have attempted to assess the relationship between hsCRP and dietary 
factors. Hickling and colleagues have reported that after controlling for BMI, CRP 
concentrations are significantly related to dietary factors (Hickling et al., 2008), including 
PUFA intake. Among healthy individuals, hsCRP was reported to be inversely related to 
dietary PUFA, after adjustment for other predictors of inflammation, intake of the n-3 
fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), (Pischon et 
al., 2003), although intervention studies have been less decisive (Madsen et al., 2003).
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4.4.2 Effects of physical activity on serum soluble ICAM-1
Intercellular adhesion molecule-1 (ICAM-1), which plays a key role in leukocyte 
migration and activation, is up-regulated on activated endothelial cells. Serum 
concentrations of its soluble form, sICAM-1, have reportedly been increased in athletes 
after exercise, whereas its expression on leukocytes was correspondingly reduced, 
affecting their ability to attach to endothelium (Monchanin et al., 2007). Although long 
duration exercise was found to be associated with an increase in serum ICAM-1, the 
effects of acute exercise were less evident in healthy men (Jilma et al., 1997). Results 
from this study showed that serum sICAM-1 concentrations were higher in the gymnasts 
compared to the control group, and in multivariate analysis, sICAM-1 levels were related 
to levels of physical activity. It has been reported that a high fat meal can cause a 
significant increase in plasma concentrations of adhesion molecules, including ICAM-1, 
which is abrogated by ingestion of vitamins C and E (Nappo et al., 2002). In univariate 
analysis, the findings show that serum sICAM-1 was positively associated with dietary 
fat in gymnasts, but just failing to reach statistical significance in the controls. Wegge 
and his colleagues have previously reported that dietary fat restriction, high fibre and 
daily, physical activity training caused significant reductions in body weight, BMI, CRP 
and serum ICAM-1 levels, in postmenopausal women at risk of CAD (Wegge et al.,
2004).
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4.4.3 Relationship between Hsp27 antigen, antibodies, diet and 
physical activity
Hsp27 is a molecular chaperone whose expression is induced by a number of 
environmental stressors, including oxidative stress (Ferns et al., 2006). Its release may 
stimulate an auto-immune response, and this study has previously reported that Hsp27 
antibody titres are altered in patients with established CVD, or CVD risk factors 
(Ghayour-Mobarhan et al., 2008). This current study did not find that Hsp27 antigen and 
antibody titres differed between the groups of gymnasts and controls, although antigen 
concentrations were related to dietary, saturated fat intake. Dietary PUFA were 
determinants of Hsp 27 antigen concentrations and IgM antibody titres in the study 
population as a whole.
4.5 Conclusions
In the groups of young female subjects under observation, serum hsCRP concentrations 
were found to be related to levels of physical activity, independent of BMI, and were 
lower in gymnasts. A marker of endothelial activation, ICAM-1 was also related to 
physical activity and was significantly higher in gymnasts. Although Hsp27 antigen and 
antibodies (IgG and IgM) did not differ between the groups, they were affected by dietary 
factors, and specifically dietary saturate.
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Chapter 5
Association between concentrations of 
serum antioxidant and markers of 
inflammation and indices of bone health
147
5 Association between concentrations of serum antioxidant and
markers of inflammation and indices of bone health
5.1 Introduction
Bone formation and remodelling are normally a balanced dynamic activity, with bone 
formation being undertaken by osteoblasts and bone lysis by osteoclasts (Figura et al.,
2005). Osteoclasts affect calcification in bone by a complex process, in which the 
production of free radicals may play a role (Yang et al., 1998).
Osteoporosis is a potentially preventable condition, that is associated with a significant 
morbidity and mortality. Many factors, including pro-inflammatory cytokines, have been 
implicated in the pathogenesis of osteoporosis. In adolescent females, individuals with 
high levels of physical activity were shown to have greater bone mineral density (BMD). 
In 2005, Tobias and his colleagues have found that adolescent female dancers had 
significantly higher BMD at the lumbar spine, the femoral neck, Ward's triangle (a 
triangular area within the femoral neck in which the trabeculae are normally thin and 
loosely arranged) and trochanter, which were greater when compared to non-dancers 
controls of the same (p<0.05, p<0.001), respectively (Tobias et al., 2005). Barkai and his 
colleagues (2007) also found that adolescent female athletes within the higher tertile of 
total weight bearing exercise had significantly greater BMD at the spine (p=0.009), total 
hip (p=0.03), trochanter (p=0.03), and total body (p=0.009) after controlling for age and 
BMI (Barkai et al., 2007). Over a period of 3 years, trained gymnasts had a greater
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increase in their total body, trochanter, and total hip areal BMD, and total body and 
lumbar spine BMC (p<0.05), compared to non-gymnasts. Zanker and his colleagues 
have also reported greater BMD in gymnasts as young as 7-8 years old (Zanker et al.,
2003), and American adolescent females with accumulative sports/exercise from age 12, 
had higher femoral neck BMD at age 18 years old (r=0.42, p<0.0001), and with femoral 
neck and shaft BMD at age 20 (p= 0.07-0.19, p<0.05) (Lloyd et al., 2002). These studies 
have reported greater bone mass or density in adolescent, female gymnasts than controls.
Antioxidants are important components of several biological systems, being protective 
against the adverse effects of ROS and their roles in pathogenesis, the incidence of 
prevalence of atherosclerosis, cardiovascular diseases, carcinogenesis, and aging, which 
have increased in the modem era (Halliwell and Gutteridge, 1984; Nohl, 1993). Also 
ROS also appear to play a specific role in bone re-modelling (Yang et al., 1998).
Selenium is an essential micronutrient for thyroid hormones for normal development, 
growth, and metabolism. Furthermore, selenium is found as selenocysteine in the 
catalytic centre of enzymes protecting the thyroid from free radicals damage (Triggiani et 
al., 2009). To study the effect of selenium deficiency on bone metabolism in growing 
male rats, which were fed a selenium-deficient diet for two generations, has shown that 
rats had undergone a growth retardation, induced by selenium deficiency, that is 
associated with impaired bone metabolism and osteopenia in the second-generation 
(Moreno-Reyes et al., 2001). The effect of antioxidants in controlling ROS formation is 
also well established (Frei, 1994). In view of glutathione peroxide and bone health in
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animal experiments, Petrovich and his colleagues have reported that malondialdehyde in 
the blood of rats increased from 1 to 2 weeks, after mandibular bone fracture, at stages of 
cellular fibrous and chondroid callus formation. However, the increase in 
malondialdehyde concentration was reduced after treatment with glutathione peroxidase 
(Petrovich et al., 2004).
C-reactive protein (CRP) is an acute phase reactant that increases in response to tissue 
damage, inflammation and infection (Weinhold and Ruther, 1997; Byrne et a l , 2002). 
Levels of CRP are related to interleukin-6 (IL-6), a pleiotropic cytokine, that has a direct 
effect on hepatic production of CRP (Baumann and Gauldie, 1994).
IL-6 is a potent mediator of the inflammatory process and has been shown both to 
increase with estrogen deficiency and to correlate with late-life diseases and conditions, 
including osteoporosis and cancers (Ferrari et al., 2003). Whilst some studies have found 
no correlation between IL-6 and bone mineral density (BMD), (Kania et al., 1995), others 
have shown increased levels of inflammatory markers, such as CRP and IL-6, in 
association with progressive bone loss or osteoporosis, indicating a possible 
inflammatory mechanism for osteoporosis (Scheidt-Nave et a l , 2001).
In bone, ICAM-1 is expressed on the surface of osteoblasts (Obs) and its counter­
receptor, leukocyte function-associated antigen-1 (LFA-1; CD 11a), is found on the 
surface of osteoclast (Oc) precursors. ICAM-1 blockade between the Ob and the pre-Oc 
results in an inhibition of Oc recruitment and a modulation of inflammation, which could 
potentially help in controlling disease activity in bone pathologies (Lavigne et a l , 2005).
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Hsp27 enhances the activation of the NF-kB pathway, that controls several processes, 
such as cell growth and inflammatory and stress responses (Parcellier et al., 2003). The 
cytoprotective properties of Hsp27 result from its ability to modulate ROS and to raise 
glutathione levels (Mehlen et al., 1996). Hsp27 may also be involved in cell 
differentiation (Arrigo, 2005). Changes of Hsp27 levels were observed in embryonic 
stem cells, normal B-cells, and B-lymphoma cells, which are produced from bone 
marrow and osteoblasts. Some antibodies, which are produced by B cells, have been 
shown to be implicated in certain auto-immune diseases, such as rheumatoid arthritis and 
systemic lupus erythematosus (Tuscano et al., 2005).
Hsp27 is categorized as a member of the small heat shock protein (sHsp) family and as 
the name suggests, has a molecular weight of 27kDa. This protein is like the other Hsps 
in that it functions as a molecular chaperone, but it has also been reported as having other 
actions, and one of these is its potential role in vascular disease (Ferns et al., 2006). 
Hsp27 is localised in the myocardium, skin, platelets, lymphoid and breast tumours, as 
well as ovarian and endometrial carcinomas, amongst other areas (Ciocca and 
Calderwood, 2005).
Heat shock proteins are produced by all cells and play an important role in cell protection 
in response to stressful stimuli, thus helping to protect from cell damage such as 
apoptosis and cell necrosis (Kirchhoff et al., 2002). Broadly speaking and depending on 
cellular conditions, the Hsps have two functions; this is the state of ‘non-stressed’ and
‘stressed’ conditions within a cell (Comelussen et al., 2001). They show a marked 
increase in expression during exposure to varied stressful insults (Ferns et al., 2006). 
Such stressful insults include elevated temperature, oxidised low density lipoprotein 
(LDL), ischaemia or mechanical damage and infections (Xu, 2001).
We have examined the effect of physical activity on the association between trace 
elements (Se, Cu, Zn, and Mg), antioxidants enzymes (GPx, and SOD) and markers of 
inflammation (CRP, ICAM-1, Hsp27) and BMD, in a sample of adolescent, female 
gymnasts, compared with sedentary controls of the same age. Our hypothesis was that 
higher levels of inflammatory markers, due to physical activity, may be associated with 
lower bone density, andin particular, when Hsp27 response index of stress is associated 
with intense physical activity.
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5.2 Methods
5.2.1 Bone measures
Bone mineral content, which can be expressed as bone BMC (g), refers to total weight in 
grams of bone mineral as hydroxyapatite, within a measured bone region. Bone mineral 
density BMD (g/cm ) refers to grams of bone mineral per unit of bone volume scanned. 
BMD explains about 75-90% of the variation in bone strength. The remaining variation 
can be explained by factors such as bone architecture, which affects the ability to 
withstand stress (Waud et a l , 1992). Both mineral density and content are influenced by 
the size, shape and orientation of the bone, reflecting the age, height and weight of the 
subject. BMC and BMD provide no information about the internal structure of bone. 
Bone mineral apparent density (BMAD) (g/cm3) tends to minimise the confounding 
effect of bone size on the results. Apparent density estimates the volumetric density of 
bone, and is equal to the BMC divided by an estimate of bone volume, which is obtained 
from the densitometry-derived area and other skeletal length measurements (Katzman et 
a l , 1991).
Bone mineral content (BMC, g) and density (BMD, g/cm2) of the lumbar spine (LS, 
lumbar vertebrae 2-4) and total body (TB) including arms and legs, and the hip (including 
femoral neck (FN), trochanter (TR), were assessed by dual energy x-ray absorptiometry 
(DXA, Lunar DPX) at the Osteoporosis Centre at Southampton General Hospital. 
Pediatric software (version 4.x) was used for the children and adult. Fat free soft tissue
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(FFST) and percentage body fat were obtained from the whole body scan. To account for 
differences in bone size, bone mineral apparent density (BMAD) of LS was calculated 
(Katzman et a l 1991). Precision (CV, co-efficient of variation) values on the DXA were 
1.4% for LS and 2.1% for FN (Petley et a l  2000). Whole year BMC accrual (BMC 
velocity, g/year) was calculated for each subject by dividing the difference between the 
annual distance measurements by the age increment.
Quantitative Ultrasound (QUS) measurements o f ultrasound velocity (VOS, m/s) and 
broadband ultrasound attenuation (BUA, dB/MHz) were undertaken at the calcaneus, 
using a Contact Ultrasound Bone Analyser (CUBA, McCue Ultrasonics Ltd., Winchester, 
UK). Pediatric software was used for children and adult. Two consecutive measurements 
were taken at each foot and the mean was calculated. No significant differences between 
the results of right and left foot were found, and all presented results are from left foot. 
All the measurements were taken by one investigator to ensure minimal variation. The 
CV for BUA using a heel-model (phantom), measured regularly over a period of one 
month, was 5.9%. The short-term precision of measurements in children (three repeated 
measurements on five individuals) varied between 1.2% and 5.4%, long term (repeated 
measurements on same subjects three weeks later), between 1.8% and 7.6%.
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5.3 Statistical analysis
Statistical analysis was performed using SPSS (Chicago, versionl5, 2007). Data are 
expressed as mean ± SEM, unless otherwise stated. Normality of the distribution of 
variables was confirmed using the Kolmogorov-Smimov (K-S) test, and parametric or 
non-parametric tests were applied accordingly. Comparisons of anthropometric and other 
data at baseline between gymnasts and controls were performed, using independent t-test 
or Mann-Whitney tests. A p < 0.05 was considered to be statistically significant. A 
univariate model was initially used to investigate the association between antioxidants, 
physical activity and bone measures (TBMD, TBMC, BUAR, BUAL, LSBMD, LSBMC, 
and LSBMA). Pearson product moment correlation co-efficients, between bone mineral 
content (BMC) and dietary factors, were assessed using SPSS. Stepwise multiple 
regression models were used to assess which of the confounding variables could 
influence antioxidant enzyme concentrations. Bone markers were entered into the 
regression equation separately as the dependent variables; inflammatory markers (hsCRP, 
sICAM-1, Hsp27, IgM, and IgG) were then entered as independent variables.
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5.4 Results
5.4.1 Association between antioxidants and trace elements status with 
bone health indices in controls and gymnasts.
The association between serum antioxidant enzymes (GPx and SOD), trace elements (Se, 
Zn, Cu and Mg) and markers of bone density were investigated as follows: Broadband 
Ultrasound Attenuation (BUA) right foot, BUA left foot, lumbar spine L2-L4, bone 
mineral density (L2-L4 BMD), lumbar spine L2-L4 bone mineral content (L2-L4 BMC), 
total body bone mineral density (BMD). The correlation was undertaken according to the 
normality test.
As shown in the Tables 5.1, 5.2, and 5.3, serum Zn was positively correlated with BUA 
in the gymnast group, compared to the controls (r = 0.411, and 0.476; p<0.01), and serum 
Zn showed a positive correlation with lumbar spine L2-L4 bone area (r = 0.328; p<0.05). 
Mg also showed a positive, significant correlation with BUA left foot in the gymnast 
group, compared to the controls (Figure 5.1). The results remained significant with 
partial correlations between Zn, Mg, and the bone density, when adjusted for BMI.
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Table 5.1 Spearman correlation co-efficients for non-parametric variables, between 
serum antioxidants and trace elements, including selenium, zinc, copper and magnesium, 
and bone mineral content in gymnasts and controls.
Control (n=40) Gymnast (n=38)
Spearman / Correlations Mg Zn Mg Zn
(mcmol/L) (mcmol/L) (mcmol/L) (mcmol/L)
TBMC (g) -0.08 0.02 -0.06 0.34*
LS 2-4 BMC (g) -0.06 0.05 -0.11 0.32*
* Correlation is significant at the 0.05 level (2-tailed); Mg, Magnesium; Zn, Zinc;
TBMC, Total body bone mineral content; LS 2-4 BMC, Lumbar spine L2-L4 bone 
mineral content.
Table 5.2 Pearson correlation co-efficients for parametric variables, between serum 
antioxidants and trace elements, including selenium, zinc, copper and magnesium, and 
bone mineral content in gymnasts and controls.
Control (n=40) Gymnast (n=38)
Pearson / Correlations Mg %n Mg ^n
_ (mcmol/L) (mcmol/L) (mcmol/L) (mcmol/L)
TBMD (g/cm2) 0.04 0.04 -0.09 0.22
BUA-R (dB/MHz) -0.05 -0.06 0.21 0.41**
BUA-L (dB/MHz) 0.07 -0.01 0.33* 0.48**
LS L2-L4 BMD (g/cm2) 0.02 0.09 -0.09 0.23
LS L2-L4 BA (g/cm3) -0.08 0.00 -0.13 0.33*
* Correlation is significant at the 0.05 level (2-tailed), ** Significant at the 0.01 level (2- 
tailed); TBMD, Total body bone mineral density; TBMC, Total body bone mineral
content; BUA RF, BUA right foot; BUA LF, BUA left foot; LS 2-4 BMD, Lumbar spine 
L2-L4 bone mineral density; LS 2-4 BMC, Lumbar spine L2-L4 bone mineral content; 
LS BA, Lumbar spine L2-L4 bone area.
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Table 5.3 Partial correlation co-efficients between Mg, Zn, and bone mineral content in 
gymnasts and controls, when adjusted for BMI.
Control (n=40) Gymnast (n=3 8)
Partial Correlations Mg Zn Mg Zn
_____________________________ (mcmol/L) (mcmol/L) (mcmol/L) (mcmol/L)
BUA-R (dB/MHz) -0.00 0.05 0.33* 0.34*
BUA-L (dB/MHz) 0.13 0.00 0.43** 0.41**
TBMC (g) -0.04 0.20 0.08 0.33*
TBMD (g/cm2) 0.11 0.24 0.09 0.19
LS L2-L4 BMD (g/cm2) 0.08 0.25 0.07 0.28
LS L2-L4 BMC (g) 0.01 0.20 0.00 0.34*
LS L2-L4 BA (g/cm3) -0.05 0.13 -0.01 0.33*
* Correlation is significant at the 0.05 level (2-tailed), ** Significant at the 0.01 level (2- 
tailed); TBMD, Total body bone mineral density; TBMC, Total body bone mineral
content; BUA RF, BUA right foot; BUA LF, BUA left foot; LS 2-4 BMD, Lumbar spine 
L2-L4 bone mineral density; LS 2-4 BMC, Lumbar spine L2-L4 bone mineral content; 
LS BA, Lumbar spine L2-L4 bone area; TBMC, Total body bone mineral content; LS 2-4 
BMC, Lumbar spine L2-L4 bone mineral content.
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5.4.2 Association between dietary factors and bone markers in female 
gymnasts and controls.
As shown in the Tables 5.4 and 5.5 in the gymnast group, most of the positive findings 
were found in relation to the lumbar spine 2L-4L bone area. There was a positive, 
significant correlation between LSBA and dietary factors (energy, protein, fat, dietary 
SFA), and between BUA left foot and protein (r = 0.32, p<0.05; r = 0.43, p<0.01; r = 
0.31, p<0.05; r = 0.37, p<0.01 and r = 0.40, p<0.05), respectively. Significant correlation 
were found between TBMD and dietary protein (r = 0.33, p<0.05). TBMC and dietary 
factors (protein, fat, and dietary SFA) (r = 0.44, p<0.01; r = 0.29, p<0.05; r = 0.36, 
p<0.01). Between BUA right foot and energy (r =0.31, p<0.05); and between BUA left 
foot and dietary factors (energy, dietary SFA, and dietary fibres) (r = 0.33, p<0.05; r = 
0.34, p<0.05; r = 0.31, p<0.05). There was also a positive correlation between lumbar 
spine L2-L4 of BMC and dietary factors (protein and dietary SFA) (r = 0.38, p<0.01; r = 
0.33, p<0.05). Partial correlation was used to explore the association between bone 
markers and dietary factors when controlled for BMI.
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5.4.3 Association between bone health indices and anthropometric and 
physical activity
As shown in Table 5.6, partial correlations were found to be significant between bone 
markers (TBMD, TBMC, BUA RF, BUA LF, LS 2-4 BMD, LS 2-4 BMC, and LS BA) 
and anthropometric (skin fold fat percentage, mid-arm circumference, and physical 
activity), which have shown results between p<0.05 and p<0.01, and were calculated by 
using SPSS.
T
a
b
le
 
5.6
 
P
a
r
ti
a
l 
p
r
o
d
u
c
t 
m
o
m
e
n
t 
c
o
r
r
e
la
ti
o
n
 
c
o
-e
ff
ic
ie
n
ts
 
b
e
tw
e
e
n
 
a
n
th
r
o
p
o
m
e
tr
ic
 
m
e
a
s
u
r
e
s
 
an
d
 
p
h
y
s
ic
a
l 
a
c
ti
v
it
y
 
in 
g
y
m
n
a
s
ts
 
a
n
d
 
c
o
n
tr
o
ls
 
w
h
e
n
 
a
d
ju
st
e
d
 
fo
r 
B
M
I
.
oo
cn
o
o
o
£c
o
u
<  ICu •*“<
a
0 3  p L |
3  d
* * * *
* * * *
oo i n IN 1—1
IN 00 i n vo
© © o ©
CN i n 00
o o © CN
o ' o 1 ©i ©1
* * * *
* * * *
oo o CN VO
m i n m
o © © ©
* * * *
* * * *
i n o cn cn
m SO r r
© © © ©
o
ocn
O
oo
o
o
tsaco
'51) 3
p u
§ 3
PQ PQ
H H
cn
CN
r-
o
N
PQ
3
P4
d
PQ
CN
CN
PQ
3
P htJ
PQ
*
*
cn
i n
©
cn
o
*
om
o
in
**
CN00
in
o
**
o00
OS
o
* * *
Os 00 vocn cn cn
© © ©
* * ** * *
i—l CN oo
i n i n
© ©* ©
CN
m
o
(N
d
o
a t) /oq
s—^
Q O
3 3
PQ PQ
CN CN
C/3 C/3
t J
ao
w
<
PQ
00h-J
PQ
03
•1—I «
a -
oS
</3
03
*
164
5.4.4 Association between bone mineral density (BMD) and markers 
of inflammation
Association between markers of inflammation and auto-immunity (sICAM, hsCRP, 
Hsp27, IgG, and IgM) and the indices of bone health, broadband ultrasound attenuation 
(BUA) right foot, BUA left foot, lumbar spine L2-L4 bone mineral density, lumbar spine 
L2-L4 bone mineral content, and total body bone mineral content (BMC) were 
investigated using Pearson product moment correlation co-efficients. As shown in the 
Table 5.7 and Figures 5.2 and 5.3, there were significant correlations between markers of 
inflammation in serum (sICAM, Hsp27, IgG, and IgM) and bone mineral density 
(TBBMD, TBBMC, LSBMD, LSBMC, and LSBMA). Partial correlations were used to 
explore the association between bone mineral density and markers of inflammation 
comparing gymnasts and controls, when controlled for BMI. As shown in Table 5.8, 
association between bone mineral density and markers of inflammation were investigated 
using partial correlations.
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5.4.5 Multiple regression analysis
Achievement of high peak bone mass during adolescence is thought to be a critical factor 
in preventing osteoporosis in adulthood (Laing et ah, 2002; Lloyd et al., 2002). The 
physical activity appears to be a promising way to increase bone mass among children 
and adolescents. Jones & Dwyer (1998) showed that physical activity among 8 year old 
girls was associated with bone mass and persisted after adjustment for body size and lean 
body mass (Jones and Dwyer, 1998). Zhu et ah (2004) found that physical activity was a 
significant predictor of total BMC among 9-11 year old pre-menarchal girls. Those with 
greater physical activity had greater distal and proximal forearm BMC (Zhu et ah, 2004). 
The current study has taken into account potentially confounding variables by using 
stepwise multiple regression analysis, in which bone mineral indices (TBMD, TBMC, 
BUAR, BUAL, LSBMD, LSBMC, and LSBMA) were entered into the equation 
separately as the dependent variables; inflammatory markers (hsCRP, sICAM-1, Hsp27, 
IgM, and IgG), and antioxidants (GPx, SOD, Se, Cu, and Zn) were then entered as 
independent variables. In addition, height, weight, or BMI were also entered as shown in 
Tables 5.9 to 5.11.
With regard to the inflammatory markers and bone mineral for the gymnast group, after 
height and weight have been entered into the equation, it was found that weight was the 
most significant predictor of total bone mineral content, contributing approximately 93%, 
with total body bone mineral density, lumbar spine L2L4, bone mineral content and 
density of the variations. Standing height was the most significant predictor o f lumbar
170
spine L2L4 bone mineral area, contributing approximately 79% and with both left and 
right broadband ultrasound attenuation (BUA) of the variations. 1% of the variation in 
the left broadband ultrasound attenuation was explained by antibody IgM.
In the control group, height was also the most significant predictor of lumbar spine L2L4 
bone mineral area, contributing approximately 86%, with total body bone mineral 
content, lumbar L2L4 bone mineral density, and right broadband ultrasound attenuation, 
where weight was the most significant predictor variation, with total body bone mineral 
density, and lumber spine L2L4 bone mineral density (42% and 54%), respectively. 2% 
of the variation in left broadband ultrasound attenuation was explained by Hsp27, Table 
5.10.
With regard to the inflammatory markers and bone mineral for the gymnast group, after 
BMI has been entered into the equation, the body mass index was the most significant 
predictor with all bone markers, except that left broadband ultrasound attenuation 
explained Hsp27 (16%).
sHsp27 in the control group was the significant, predictable variation for TBBMD, BUR 
right, and BUR left (22%, 26%, and 22%) respectively, as shown in Table 5.10.
With regard to the antioxidants, trace elements and bone mineral for the gymnast group, 
after weight and height have been entered into the equation, the weight was the most 
significant predictor with TBBMD, TBBMC, LS L2L4 BMD/C/A, where LS L2L4 
BMA, BUA/L/R were explained by height, and Zn was the predictor of left broadband 
ultrasound attenuation (5%).
171
In the control group, weight and height, in addition to GPx, were the predictor’s 
variations for bone marker as shown Table 5.11.
With regard to the antioxidants, trace elements and bone mineral for the gymnast group, 
after BMI has been entered into the equation, 59% of the variation was explained by 
TBBMC, and with TBBMD, LS L2L4 BMD/C/A, and right BUA. 25% of the variation 
in left BUA was explained by Zn and Cu which was 10%. In the control group, BMI was 
the only predictor of bone density variations, as shown in Table 5.12.
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5.5 Discussion
5.5.1 Physical activity and bone markers
In the current study, all the measures of bone density mineralisation (TBMD, TBMC, 
BUAL, BUAR, LS 2-4 BMD, LS 2-4 BMC, and LS BA) were positively associated with 
physical activity (r= 0.48, 0.50, 0.52, 0.56, 0.39, 0.38, 0.36 respectively), with a trend 
towards significance (p-value between 0.05 and 0.01), as shown in Table 5.6. The effect 
of physical activity on TBMCLS 2-4 BMC, BUAL, BULR, and LS BA were even better 
demonstrated with trace elements (Zn, and Mg), as they contributed significantly to the 
variation, with adjustment for the main confounders of this study. Further, when 
adjusting for BMI as additional confounders, the contribution of the physical activity 
with bone markers’ variation further increased and p-value reached significance. The 
results show an increase in both total body bone mineral density and total body bone 
mineral content in adolescent gymnasts than in controls, (16.74 ± 6.7 vs. 14.86 ± 
6.2g/cm2; 0.94±0.01 vs. 0.84±0.01g). With regard to lumbar spine (L2-L4) bone 
mineral density, content was higher in gymnasts compared to controls (0.85±0.02; 
26.07±1.49 vs. 0.90±0.02; 24.45±1.22g/cm3), respectively. Lumbar spine (L2-L4) bone 
mineral area was significantly higher with gymnasts in comparison to controls 
(29.50±0.96 vs. 26.49±0.71g/cm3; P<0.05). It may therefore be concluded from this 
research that greater physical activity has been associated with greater peak bone mass 
attainment. In a longitudinal study, Laing and his colleagues (2002) showed that 
gymnasts possessed significantly higher areal BMD at the lumbar spine, total hip,
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femoral neck, trochanter, and distal radius at baseline compared to non-gymnasts 
(p<0.05) (Laing et al., 2002).
The results therefore indicate that general physical activity enhances bone density, and 
this connection has also been highlighted in many other research findings (Ringsberg et 
al., 2001; Schulzke et al., 2007; Forwood, 2008; Tolomio et al., 2008). Many 
researchers have provided evidence of an overall improvement on bone density with a 
physically active lifestyle. Consequently, the studies on children and exercise have 
improved our understanding of the effect of high levels of mechanical loading on 
growing bone. Both cross sectional and short-term follow up studies have indicated 
higher bone mass (g/cm2) in adolescent gymnasts, than in controls (Cassell et al., 1996; 
Taaffe et al., 1997; Nickols-Richardson et a l , 1999; Havas et al., 2000).
5.5.2 Antioxidant and bone markers
Antioxidant enzymes, such as glutathione peroxide, may play an important role in the 
pathophysiology of primary male osteoporosis. The results of this study have found a 
negative correlation between glutathione peroxidase (GPx) and bone density, bone 
mineral content, lumbar spine bone density / mineral content / and area in the gymnast 
group. As far as antioxidants are concerned, these have decreased. Therefore, the 
suggestion is that oxidative stress may play an important role in the pathophysiology of 
primary male osteoporosis. A negative correlation between GPx and lumbar BMD has 
been shown previously (Yalin et al., 2005). SOD has also been implicated in the
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pathophysiology of primary osteoporosis; some studies have reported that an increase in 
free radical levels may compromise the antioxidant defences in osteoporotic patients 
(Sanchez-Rodriguez et a l, 2007). Yalin and his colleagues have shown a negative 
correlation between SOD and lumber bone mineral density (Yalin et al., 2005). The 
findings from this study have also found a significant association between serum SOD 
with lumber bone mineral density and also with bone density, bone content, and bone 
area. Selenium was not significantly related to bone density, which has also been shown 
by Liu and his colleagues, which compares selenium and iron with bone mineral density 
(Liu et al., 2009).
5.5.3 Dietary intakes and bone markers
Some studies have shown that dietary supplementation with trace elements may affect 
bone formation (Wilson et al., 1981; Katz et a l,  1984; Strause et al., 1987). Nawroth 
and his colleagues have shown that there is a link between decreased bone mass and an 
increase in cardiovascular mortality (Nawroth et al., 2003). Additionally, Baldini et al. 
(2005) have shown a possible link between trace elements and matrix proteins (collagen, 
proteoglycan, and osteonetine), which may play an important role in bone formation 
(Baldini et al., 2005) and bone density formation (Popat et a l,  2009). In terms of 
macronutrients, the correlation was more significant with the control group than the 
gymnast group, especially between energy, protein and dietary SFA and bone mineral 
density.
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5.5.4 Inflammation and bone markers
When children are exposed to inflammation associated with malnutrition and lack of 
physical activity during puberty, they may develop growth retardation. High protein 
food intake and physical activity enhances GH secretion, which may lead to alterations 
in serum IGF-1 concentrations (Issenman, 1999). In addition, the cumulative effect of 
physical activity may profound immunity and inflammatory mediators, which includes 
pro-inflammatory cytokines like TNF-a and IL-6, known to inhibit GH and IGF 
(Sheweita and Khoshhal, 2007). Animal experiments have shown that a deficiency of 
copper, or zinc, can lead to enhanced Cytochrome P-450 activity in microsomes of liver 
and lung, which stimulates ROS generation, increasing iNOS expression 
(Hammermueller et a l, 1987). Selenium deficiency may also be associated with 
reduced tissue glutathione peroxidase activity, which may result in per-oxidative 
induced damage (Xia et al., 1985). In addition, it leads to reactive oxygen related 
damage. Cumulative effects of physical activity can increase the production of ROS, as 
a response to inflammation; oxidative stress markers may be an important indicator for 
bone loss in postmenopausal women. Furthermore, antioxidant enzyme activity, such as 
GPx or SOD, are affected by an increase of oxidative stress (lipid peroxidation end 
production malondialdehyde (MDA)), where Nitric oxide (NO), which is the normal, 
biological process of bone cell function was reduced, as a result of the oxidation (Yalin 
et a l, 2005; Ozgocmen et a l, 2007). Therefore, SOD was lower in the gymnast samples 
when compared to the controls.
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With respect to the correlation between bone mineral and markers of inflammation, a 
significant negative correlation has been shown between sICAM and Hsp27 and bone 
mineral in general, among the adolescent gymnasts.
It has previously been reported that in stable haemodialysis patients, abnormal bone 
mineral metabolism was associated with increased, soluble adhesion molecules. These 
changes in adhesion molecules may be associated with the development of 
cardiovascular changes and contribute to high, cardiovascular morbidity and mortality in 
patients with abnormal mineral metabolism, (Arid et al., 2006). When calcium and 
phosphorus metabolism is perturbed for any reason, e.g. dietary deficiency, kidney 
diseases or parathyroid disease (increased calcium mobilised in the kidney), 
l,25(OH)2D3 interacts with its receptor in osteoblasts and induces the expression of 
receptor activator of nuclear factor (NF)-kB ligand, which interacts with osteoclasts 
(Holick, 2004). Bone and cartilage consist of distinct collagens, type I and type II, 
which are specific products of different osteoblasts or osteoblast like cells. Shroff and 
his colleagues have observed that Hsp47 was more abundantly localised in regions of 
type I collagen (Shroff et al., 1993), because it serves as a chaperone protein for 
collagen (Daffom et al., 2001). Collagen synthesis can therefore increase with physical 
activity, possibly linking HSP and bone minerals in the role of oxidation stress. Several 
studies have shown that levels of collagen synthesis and matrix metalloproteinases also 
increase with mechanical loading (Kjaer et al., 2005).
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BMI has been used by the WHO as the standard for recording obesity statistics since the 
early 1980s. In most countries, BMI is also used to define underweight, as a support for 
those suffering with eating disorders, such as anorexia nervosa and bulimia nervosa. 
BMI can be calculated quickly and without expensive equipment. However, BMI 
categories do not take into account many factors such as frame size and muscularity. 
Despite this, BMI categories are regularly regarded as a suitable tool for measuring 
whether sedentary individuals are underweight, overweight or obese, with various 
qualifications, such as individuals who are not sedentary (Jeukendrup and Gleeson, 
2004).
The Body Mass Index has generally been used as a means of correlation between groups 
related by general mass. This general correlation is particularly useful for consensus 
data regarding obesity, or various other conditions. As it can be used to build a semi- 
accurate representation from which a solution can be stipulated, this is becoming more 
and more relevant to the growth of children, due to the majority of their exercise habits; 
the growth of children is therefore usually documented against a BMI-measured growth 
chart (Barasi, 1997).
The differences in the associations in BUA between the left and right foot, has been also 
been reported previously by other researchers, and may be due to anatomical reasons 
(Dretakis et al., 1994).
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5.6 Conclusion
Obtaining adequate levels of antioxidants, such as trace elements, may help growth of 
the bone by preventing inflammations and enhancing metabolic reaction inside the 
body.Consequently, diet and trace elements are associated with bone density. Among the 
trace elements, zinc and magnesium were significantly higher among gymnasts, in 
comparison to controls. Generally, dietary factors have shown less significant 
correlation among gymnasts, in comparison to controls. In terms of physical activity and 
bone density, a significant correlation was found in the gymnast group, as opposed to 
any significance in the control group. However, other anthropometric studies have 
shown a significant correlation with bone in both gymnast and control groups, although 
the gymnast group had a higher, significant correlation in comparison to the controls. 
With regard to markers of inflammation and bone mineral density, the results have 
indicated a significant correlation between gymnasts and controls, in terms of sICAM, 
hsCRP, sHsp27, antibody IgG, and antibody IgM; where gymnast is compared to the 
control, this may be regarded as a unique finding..
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6.1 Rationale for the studies
Many studies have reported that high levels of physical activity have beneficial effects 
on the incidence of several chronic diseases that include: Coronary heart disease (CHD) 
(Reybrouck and Mertens, 2005), hypertension (Agosti et al., 2009), diabetes mellitus 
(Lazarevic et al., 2006), and osteoporosis (Warburton et al., 2006). Previous studies 
have explored the relative risks and benefits associated with increased levels of physical 
activity and also the impact of the intensity of the physical activity undertaken 
(Briazgounov, 1988; Lee et ah, 1997). The impact of increasing physical activity on 
specific risk factors for CHD and osteoporosis has also been investigated. Whilst the 
benefits of exercise on CHD and bone density appear to outweigh the hazards (Gibson, 
1987) in most cases, high levels of exercise have been reported to be associated with 
altered levels of oestrogen in women (Matthews et al., 2004), and this may adversely 
impact on bone density, leading to osteopenia in some cases (Lanyon, 1996). However, 
moderate levels of physical activity, such as walking, gardening or light sports, appear to 
have beneficial effects and are reported to lead to a 30-50% reduction in CVD in 
women: 60 minutes of cumulative, daily, physical activity may help in the prevention of 
osteoporosis (Beitz and Doren, 2004). One particular problem associated with previous 
studies has been the lack of data on dietary intake. Individuals who are physically active 
may also have substantial differences in their diet that may confound the statistical 
analysis, and for this reason, the current study has attempted to take this into account.
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Another potential problem with previous cross sectional studies is that they have often 
been undertaken in middle-aged subjects, in whom incident, sub-clinical vascular 
disease (including heart disease) is likely to be present. The measurement of serum 
biomarkers in such cases may also be confounded, being influenced as a secondary 
feature of this underlying disease.
As shown in Figure 6.1, this study has therefore investigated two groups of young, 
healthy females (between 8-17 years), living in southeast England, who differed with 
respect to their levels of physical activity, to see if there is any potential correlation 
between these different concepts of atherosclerosis, inflammation markers and bone 
mineral density, in term of physical activity. Physical activity is associated with the 
generation of reactive oxygen species (ROS), and may lead to decreased levels of 
plasma antioxidants and increased oxidant stress. Some studies have reported that 
antioxidant supplements can reduce the consequences of oxidative stress during 
exercise. This research aimed to assess the chronic effects of exercise on endogenous 
serum antioxidant enzyme concentrations. Glutathione peroxidase (GPx) and 
superoxide dismutase (SOD) activity were measured in adolescent girls who were either 
competitive gymnasts or sedentary controls. The relationship between age, body mass 
index (BMI), dietary intake, trace element status and serum GPx and SOD was 
determined.
The subjects of the current study were part of a three-year, longitudinal investigation of 
exercise and peak bone mass (PBM) development in 38 competitive gymnasts and 40
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healthy, sedentary adolescent females, aged 8-17 years. Serum GPx and SOD were 
measured using colorimetric assays and trace elements were measured using inductively 
coupled plasma mass spectrometry (ICP-MS).
A second aspect of this investigation was to assess the effects of chronic exercise on 
markers of inflammation, endothelial activation and auto-immunity in the absence of the 
potential, confounding effects of incident atherosclerosis. The subjects comprised 25 
competitive gymnasts and 19 healthy, sedentary adolescent females. Serum soluble 
intercellular adhesion molecule 1 (sICAM-1), high sensitivity C-reactive protein 
(hsCRP), heat shock protein 27 (Hsp27) and Hsp27 antibody titres were measured by 
ELISAs in a sample of adolescent girls, who were either physically active (competitive 
gymnasts), or sedentary. The association between ages, body mass index (BMI), dietary 
intake, serum hsCRP, sICAM-1 and Hsp 27 antigen and antibody titres, were 
determined.
The last part of these studies aimed to assess the effects of chronic exercise on bone 
mineral density, with the participation of 38 competitive gymnasts and 40 healthy, 
sedentary adolescent females, aged 8-17 years. The attainment of optimal peak bone 
mass during teenage years is key in the primary prevention of osteoporosis (Bianchi, 
2007). Although competitive sport is suggested to have an adverse effect, menarche 
status is also relevant during exercise; when subjects were categorised according to 
menarchal status, post-menarchal girls were shown to be significantly taller and heavier
187
compared to those girls who are non-runners, with higher fat mass and significantly 
higher total body and lumbar spine BMD (Lucas et al., 2003).
6.1.1 Diet, physical activity, antioxidants, and markers of CVD risk
It has been reported previously in a large, mixed gender sample that serum 
concentrations of several trace elements may be affected by dietary intake, physical 
activity and anthropometric factors, including adiposity (Ghayour-Mobarhan et al.,
2005). In this study, the mean serum GPx concentrations were significantly higher in 
the gymnasts, compared to the sedentary females (157±11.1 versus 126±8.8 U/ml, 
p<0.05). In contrast, serum SOD concentrations were significantly lower in the 
gymnasts compared to the sedentary, adolescent females (7.24±2.6 versus 8.57±2.3 
U/ml, p<0.05). Selenium, zinc, and copper status were higher in the physically active 
group, compared to the inactive group (0.89±0.03, 10.86±0.39, 14.50±0.50 vs. 
0.81±0.03, 10.32±0.28, 14.38±0.42 pmol/L, respectively, although only serum selenium 
reached statistical significance (p<0.05). The current findings show that young, female 
gymnasts have an altered antioxidant enzyme profile, compared to their less physically 
active peers. These results are consistent with data from animal experiments (rats), in 
which antioxidant enzymes, for example serum GPx concentrations, are increased with 
physical activity (Ji et al., 1991). Another study has shown the effect of exercise on 
antioxidants in three different age groups (young, adult, and old age), where young 
animals have the highest level of antioxidants, due to exercise (Leeuwenburgh et al., 
1994). In comparison between genders, Rush and his colleagues have found that
females have higher serum GPx concentrations than males, but no increase was found in 
association with exercise (Rush and Sandiford, 2003); it is therefore possible that the 
increase of GPx activity was affected by the body weight of the adolescent gymnast 
girls. However, the mechanisms responsible for the observed gender difference in 
serum GPx levels are still uncertain. Some studies have shown that dietary 
supplementation with trace elements, such as copper, affects cardiovascular risk factors 
and bone density. Copper is an important component of lysyl oxidase that is involved in 
the biosynthesis of collagen, which is a major constituent of the extracellular matrix, and 
therefore potentially important for both cardiovascular and bone density. Deficiency of 
copper is associated with elevated serum cholesterol concentration (Klevay, 1975; 
Klevay, 1980; Klevay, 1987), increased accumulation of arterial lipid peroxides and 
impaired endothelium dependent arterial relaxation, which cause hypertension due to a 
reduction in nitric oxide (NO) (Klevay, 1987). Copper metabolism appears to play a 
role in coronary heart disease (Klevay, 1993); decreased plasma copper, ceruloplasmin, 
and superoxide dismutase activity may be associated with an increase in plasma 
cholesterol (Klevay et al., 1984) and abnormal electrocardiograms (Reiser et al., 1985). 
In addition, it is also important to bone density if bone resorption markers have 
increased with copper supplementation and/or plasma copper (Kawada et al., 2006; 
Chaudhri et al., 2009).
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6.1.2 Diet, physical activity, and inflammatory markers
hsCRP and ICAMs are both markers of inflammation, and can predict cardiovascular 
disease (Hjelstuen et al., 2006), diabetes (Freeman et al., 2002), cancer (Heikkila et al., 
2007). In some studies, CRP and ICAM have been shown to be affected by lifestyle, 
such as a diet high in fat (Witkowska, 2005; Plaisance and Grandjean, 2006). Lower 
serum hsCRP levels were found in the gymnasts, which may be related to their lower 
adiposity (body fat) and high physical activity. Cross sectional studies have reported 
that physical activity is negatively associated with hsCRP concentrations (Geffken et al., 
2001), and there have been a number of reports from cohort studies which have found 
that CRP levels are positively associated with CVD risk (Mora et al., 2006; Petersson et 
al., 2008). This study has also found that serum ICAM-1 concentrations were higher in 
young, female gymnasts, compared to sedentary controls. This was related to the high 
chronic levels of physical activity in the gymnasts, that may be associated with muscle 
injury and / or inflammation. There are other mechanisms which may account for 
increased serum ICAMs concentrations. An acute inflammatory response may result 
from tissue damage during physical activity, by affecting the production of reactive 
oxygen species, and fatty acids. This is due to the fact that free radicals are unstable 
molecules, which pretend to have a reaction and so damage various organic substrates. 
Nitrogen monoxide (NO), superoxide anions and related reactive oxygen (ROS) and 
nitrogen (RNS) species have modulating roles in certain signal transduction pathways, 
involving membrane receptors as part of various physiological processes. During 
physical activity, a potential toxic of oxygen species may be generated in one of two
ways: (1) by significant stimulation of NADPH oxidases or (2) from the mitochondrial 
respiratory chain. At the same time, in a normal cell, there is an appropriate pro- 
oxidant-antioxidant balance. However, this balance can be shifted towards the pro- 
oxidants when production of oxygen species is greatly increased as a result of physical 
and chemical effects, or when levels of antioxidants are diminished. This state is called 
“oxidative stress”, which is basically caused by two mechanisms: (1) when 
concentration of antioxidants is reduced; (2) the number of oxygen / nitrogen / carbon- 
based reactive species derived from activated phagocytes is increased, e.g. in the case of 
chronic inflammation (disease), which can induce chemical changes in several cell 
organelles, i.e.,alteration of DNA and proteins, and peroxidation of lipids (Barzilai and 
Yamamoto, 2004; Ohshima et a l , 2006). During inflammation, cytokines have played 
an important role in increasing intercellular cell adhesion molecules (Smith et al., 2000). 
Long duration exercise has been found to be associated with an increase in serum 
ICAM-1, that immune system markers, [namely soluble interleukin-2 receptor (sIL-2R), 
soluble CD8 (sCD8), soluble intercellular adhesion molecule 1 (sICAM-1), soluble 
CD23 (sCD23), soluble tumor necrosis factor receptor (sTNF-R), and neopterin], have 
induced by physical exercise (Tilz et al., 1993). In addition, an association was found 
between serum ICAM-1 concentrations and dietary fat in this study, which has also been 
reported by some other studies; that a high fat meal causes a significant acute increase in 
plasma concentrations of adhesion molecules, including ICAM-1 (Nappo et al., 2002). 
It has also been reported that serum ICAM-1 concentrations are increased acutely in 
athletes after exercise, whereas its expression on circulating leucocytes was 
correspondingly reduced, affecting their ability to attach to endothelium (Nielsen and
Lyberg, 2004). When cells were exposed to elevated temperatures, or one of several 
other stresses, they produced a number of proteins termed ‘heat shock proteins’ (Hsp) 
(De Maio, 1999). Hsp27 has been thought to play a significant role following cardiac 
events such as, ischaemia, hypertrophy and vascular wall injury (Ferns et al., 2006). 
Physiological stresses such as these cause changes to occur that affect the cells’ 
metabolic processes and structural arrangement; Hsp27 can facilitate recovery and may 
result in giving the cell survival advantages (Carper et al., 1997). The expression of Hsp 
seen in atherosclerotic plaque, may be a result of a number of factors, all of which might 
lead to the induction of Hsps in vascular, smooth muscle cells, endothelial cells and 
macrophages (Hochleitner et al., 2000). This study did not find a significant association 
between serum levels of Hsp27 antigen, or Hsp27 antibody titres (IgM, IgG) and 
physical activity. Hsps have also been linked to the pathogenesis of other diseases, such 
as arthritis (Gaston et al., 1990), multiple sclerosis (Georgopoulos and McFarland,
1993), diabetes (Tun et al., 1994), hypertension (Shams et al., 2008), and in cancer 
(Ciocca and Calderwood, 2005). Some studies have also shown that regular and 
moderate exercise have effects on the immune system by increasing serum total IgG, 
and IgM (Karacabey et al., 2005). However, some other studies have shown that 
changes in parameters of immune function were dependent on the type of physical 
exercise performed (Saygin et al., 2006). Dietary factors may decrease the production 
of inflammatory mediators through the effects on the cell signalling and gene 
expression, by reducing the effects of oxidants and promoting anti-inflammatory 
responses (Calder et al., 2009). The results of this study show that Hsp27 antigen
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concentrations were related to dietary fat intake and that dietary PUFA is a determinant 
of IgM antibody titres.
A potentially important feature of this research was the age of the participants. 
Menarche is associated with endocrine and metabolic changes. The age o f onset of 
menarche is influenced by a diverse range of factors that include hereditary, ethnicity, 
climate, psychological factors, socioeconomic status, body weight and height, nutritional 
state, body fat and exercise, together with the presence of chronic illness. A study from 
Korea has shown a change in the average menarchal age, from 14.8y to 12.5y, over the 
past 30 years (50s to 80s); they also found that seasonal patterns have an effect on 
menarche, i.e. summertime and wintertime, which were responsible for a psychological 
factor, (eg. schools start and/or physical rest), (Park et al., 1999; Sharma et al., 2009).
6.1.3 Diet, physical activity and bone density
There is a growing body of evidence suggesting an important role of training in 
optimising bone density. Physical activity, like ballet dancing, has provided a model of 
mechanical loading patterns required to site-specifically modulate bone (Matthews et al.,
2006); some data suggests that elderly men and women should consume dietary protein 
above current recommendations (0.8 g/kg/day) during physical activity, to optimise bone 
mass (Campbell et al., 2007); also, during life-schools based on physical activity, there 
was intervention evidence with respect to optimising bone development in both children 
and adolescents (Hughes et a l, 2007). All of these studies have clarified the pictures of
impacts of physical activity on bone density. Zinc deficiency is usually caused by 
insufficient dietary intake, but can be associated with some other diseases such as 
malabsorption, acrodermatitis enteropathica, chronic liver disease, chronic renal disease, 
sickle cell disease, diabetes, malignancy, and other chronic illnesses (Prasad, 2003). In 
children, it causes growth retardation, delayed sexual maturation and infection 
susceptibility (Hambidge and Krebs, 2007). Mild zinc deficiency depresses immunity 
(lbs and Rink, 2003), although excessive zinc does also (Rink and Gabriel, 2000). Over 
300 enzymes require the presence of magnesium ions for their catalytic action, including 
all enzymes utilising or synthesising ATP (Evangelopoulos et al., 2008), and human 
magnesium deficiency has been implicated in a number of human illnesses such as 
osteoporosis (Sojka and Weaver, 1995). Low and high protein intake inhibit magnesium 
absorption, and other factors such as phosphate, phytate, and fat affect absorption 
(Wester, 1987). This study has therefore found that serum Zn and Mg have a positive 
correlation with bone markers, such as (TBBMC, BUA of right foot, BUA of left foot, 
and L2-L4 BA) in the female gymnasts, but not in the sedentary controls. This remained 
significant after adjustment for BMI. Antioxidant enzymes such as glutathione 
peroxides may play an important role in the pathophysiology of primary male 
osteoporosis, where it has been shown that there is a negative correlation between GPx 
and lumbar BMD levels (Yalin et a l, 2005). Selenium-containing compounds appear to 
have important effects on bone metabolism. Following fractures in animal experimental 
models (rats), Petrovich has reported that treatment with Se can reduce the formation of 
the marker of lipid peroxidation, MDA, after mandibular bone fracturing (Petrovich et 
a l, 2004), which was oxidative stress indicative (Yeler et a l, 2005). Furthermore,
selenium deficiency is associated with impaired bone metabolism and osteopenia in 
second-generation selenium-deficient rats (Moreno-Reyes et al., 2001). Studies on 
osteoporosis have generally shown that diets low in copper can cause osteoporosis 
(Baxter et al., 1953). Bone density has also been linked to copper status; osteoblast 
activity was found to be reduced in both copper deficiency (Baxter et al., 1953) and 
human osteoporosis (Gillespy and Gillespy, 1991). A supplementation trial with trace 
elements (including copper) produced beneficial effects on bone density (Strause et al.,
1994). Copper is an essential element for several enzymes involved in bone formation, 
and studies have shown that copper reduces bone resorption activity (Wilson et al., 
1981). Copper functions as a co-factor for SOD, which acts as a scavenger of free 
radicals that are produced by osteoclasts during bone resorption (Key et al., 1990). 
Furthermore, Nawroth and his colleagues have shown that there is a link between 
decreased bone mass and an increase of cardiovascular mortality (Nawroth et al., 2003). 
Additionally, Baldini et al. (2005) have shown a possible link between trace element 
status and the synthesis of matrix proteins (collagen, proteoglycan, and osteonetine) 
which may play an important role both in bone formation and the development of 
atherosclerosis (Baldini et al., 2005). The gymnasts and controls in this study were 
matched by age for menarchal status. Both groups were self-selected in that, after 
approaching potential individuals, the decision to take part was made by the girl and/or 
parent, which helped in the process of data collection.
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6.2 Limitations of study
The study has several limitations: The collection of a fasted blood sample was the 
preferred option, but because the recruitment of subjects was through gymnastic groups 
who only met as a group in the afternoon/evening, it was not possible to collect the 
samples in this way. Estrogen and progesterone may affect copper and zinc 
concentrations in plasma, although the information on this is currently limited. It was 
not possible to calculate the dietary copper intakes of the subjects, as the version of the 
computer package employed did not have an accurate measure of copper values o f food 
groups/food items.
Also, in the cohort, it was not possible to undertake biochemical measurements of 
hormonal change and consequently, the effect of hormones on the markers assessed, has 
not been fully addressed. This information would have been helpful and is certainly an 
area for further research.
6.3 Areas for future research
It is important to undertake some further research into the effect of vitamin D 
insufficiency/deficiency on trace element status and antioxidant profiles in UK 
adolescent females. This is of particular interest, given the documented problems of low 
vitamin D status in this age group in the UK. Furthermore, it would also be useful to 
investigate the interaction with, and effect of, hormonal changes, oxidative stress 
markers and body weight, to elucidate potential mechanisms in more detail.
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6.4 Conclusions
The results of this project has shown the mean serum GPx concentrations were 
significantly higher in the gymnasts, compared to the sedentary females. In contrast, 
serum SOD concentrations were significantly lower in the gymnasts compared to the 
sedentary adolescent females. Serum selenium, zinc, and copper were higher in the 
physically active group, compared to the inactive group, but only serum selenium 
reached statistical significance (p<0.05). The mean serum sICAM-1 concentrations 
were significantly higher in the gymnasts, compared to the sedentary females. In 
contrast, serum hsCRP concentrations were substantially lower in the gymnasts, 
compared to the sedentary adolescent females. Differences remained significant after 
adjustment for anthropometric factors. In terms of bone measurements, for gymnasts, 
serum Zn was positively correlated with L2-L4 BMC, as well as BUA of the right and 
left foot. Similarly, serum Mg was positively related to the BUA of the left calcaneus. 
No significant associations were found for the control group, nor were there any 
significant associations between any other markers and indices of bone health, in either 
group.
Most previous studies have not taken into account the possibility of confounding factors 
that include anthropometric differences and dietary intake, that are also likely to vary 
between active and less active subjects. The present studyhas attempted to take these 
factors into account. The findings therefore show that young, female gymnasts have an 
altered antioxidant enzyme profile, serum inflammatory markers and endothelial
activation, compared to their less physically active peers, but there was no significant 
association with markers of bone health. However, there was a significant, positive 
association between levels of serum Zn and indices of bone mass, in this physically 
active group.
Future work should focus on examining the effect of vitamin D insufficiency on 
the above relationships and investigate further the interaction with, and effect of, 
hormonal changes and body weight.
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Appendices 1: Physical activity questionnaire.
PHYSICAL ACTIVITY • baseline, gym nast_ _ _ _ _ _ _ _ BG1
BG1 Sunday
Activity Total time Total time MET value Total energy
(hrs mins) (hrs) expenditure
Sleep 11.15 11.25 1.0 1125
Very Light 330 3.50 1.5 5.25
Light 8.45 8.75 2.5 21.88
Moderate 0.30 0.50 4.0 2.00
Vigorous 0.00 000 6.0 000
Very vigorous 0.00 0.00 10.0 0.00
2400 24.00 40.38
Monday
Activity Total time Total time MET value Total energy
(hrs mins) (hrs) expenditure
Sleep 10.45 10.75 1.0 10.75
Very Light 7.30 7.50 1.5 1125
Light 340 3.67 2.5 9.18
Moderate 1.45 1.75 4.0 7.00
Vigorous 0.20 0.33 6.0 1.98
Very vigorous 0.00 0.00 10.0 0.00
24.00 24.00 40.16
Tuesday
Activity Total time Total time MET value Total energy
(hrs mins) (hrs) expenditure
Sleep 11.00 11.00 1.0 11.00
Very Light 6.15 625 1.5 9.38
Light 2.55 2.92 2.5 7.30
Moderate 3.50 383 4.0 15.32
Vigorous 0.00 0.00 6.0 0.00
Very vigorous 0.00 0.00 10.0 0.00
24.00 24.00 43.00
Wednesday
Activity Total time Total time MET value Total energy
(hrs mins) (hrs) expenditure
Sleep 11.00 11.00 1.0 ' 11.00
Very Light 6.30 6.50 1.5 9.75
Light 3.45 3.75 2.5 938
Moderate 1.30 1.50 4.0 6.00
Vigorous 1.15 1.25 6.0 7.50
Very vigorous 0.00 000 100 000
24.00 24 00 4363
Thursday
Activity Total time Total time MET valueTotal energy
(hrs mins) (hrs) expenditure
Sleep 10.45 10.75 1.0 10.75
Very Light 7.15 725 1.5 10.88
Light 5.10 5.17 2.5 12.93
Moderate 0.30 0.50 4.0 200
Vigorous 0.20 0.33 6.0 1.98
Very vigorous 0.00 0.00 10.0 0.00
24.00 24.00 38.53
Friday
Activity Total time Total time MET value Total energy
(hrs mins) (hrs) expenditure
Sleep 11.00 11.00 1.0 11.00
Very Light 6.30 6.50' 1.5 9.75
Light 5.10 5.17 2 5  1293
Moderate 1.00 1.00 4.0 4.00
Vigorous 0.20 0.33 6.0 1.98
Very vigorous 0.00 0.00 10.0 0.00
24.00 24.00 39.66
Saturday
Activity Total time Total time MET value Total energy
(hrs mins) (hrs) expenditure
Sleep 11.30 11.50 1.0 11.50
Very Light 0.00 0.00 1.5 0.00
Light 8.10 8.17 2 5  20.43
Moderate 420 4.33 4.0 17.32
Vigorous 0.00 0.00 6.0 0.00
Very vigorous 0.00 0.00 10.0 0.00
24.00 24.00 49.25
Mean Blair Score BG1 4208
Appendices 2: Ethical approval.
S O U T H  W E S T  S U R R E Y  L O C A L  R E S E A R C H  E T H IC S  C O M M I T T E E  
Postgraduate Medical Centre,
The Royal Surrey County Hospital, Egerton Road,
Guildford, Surrey. GU2 5XX 
Teh 01483 571122 ext. 4382 Fax: 01483 303691
Chairman: Dr. J. W. W right Administrator: Mr. J. Kerslake
Our Ref: EC22/98
2 September 1998
D r S A New
Lecturer in Nutrition
School o f  Biological Sciences
University o f Surrey
Guildford
GU2 5XH
Dear Susan
Re: Influence of physical training and nutrient intake on bone health in young
adolescent females: a comparison between elite female gymnasts and healthy age-
matched controls. Information Sheet and Consent form dated 21st April 1998
Thank you for your letters o f 21 and 22 July.
I note the doses o f radiation to be used and the fact that at least one study using this 
methodology has been published in the British Medical Journal.
At its meetings on 14 July and 1' September 1998, the Ethics Committee approved the 
amendments to your study as set out in your letters o f 19 June 1998 and 6 July. The 
Committee was also content with the radiation dosage levels set out in your letter o f  21 July 
1998.
Yours/sincerely
« R J W  WRIGHT  
CHAIRMAN
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A ppendices 3: Assessment of menarche.
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Appendices 4: GPx activity blood samples o f controls and gymnast.
Controls
GPx activity 
(U/ml) Gymnasts (*)
GPx activity 
(U/ml)
C l 29.80 G2 94.11
C2 102.90 G3 87.87
C3 58.32 G4 57.43
C4 55.78 G5 38.84
C5 24.07 G6 62.14
C6 72.84 G7 87.43
C l 74.62 G8 175.36
C8 138.30 G i l 120.47
C9 138.93 G12 129.26
CIO 124.03 G13 118.18
C l l 67.75 G14 155.74
C12 122.91 G15 208.92
C13 67.50 G16 126.96
C14 142.88 G17 314.29
C17 59.80 G18 188.22
C18 172.13 G19 338.10
C20 150.90 G20 135.75
C21 61.25 G21 127.32
C24 183.51 G22 263.99
C25 208.97 G25 312.00
C l l 12.50 G27 74.17
C28 217.72 G28 163.98
C29 182.19 G29 196.71
C30 204.88 G30 158.21
C31 230.33 G31 149.08
C32 233.51 G32 130.36
C33 104.38 G33 89.10
C34 125.39 G34 212.12
C36 129.21 G35 148.57
C37 128.96 G36 196.20
C38 121.45 G37 155.96
C39 76.62 G38 187.67
C41 163.85 G39 187.03
C44 133.67 G40 173.40
C46 131.00 G41 88.34
C47 136.73 G42 129.47
C48 105.91 G43 180.41
C49 227.91 G45 101.71
C50 80.31
C51 117.12
* 157±11.1 versus 126±8.8 p/ml, p<0.05
MATERIAL REDACTED AT REQUEST OF UNIVERSITY
